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  Summary 
1. Summary 
A vast body of evidence from studies in humans as well as animals illustrates the 
pivotal role of glucocorticoid signalling during pre- and postnatal lung maturation. 
Consequently, corticosteroid treatment is the established standard regimen for pre-
term infants and has served to reduce incidence and severity of the major 
complications, respiratory distress syndrome and bronchopulmonary dysplasia. 
Glucocorticoid effects are mediated by the glucocorticoid receptor (GR) which acts as 
a ligand-dependent transcription factor and controls target gene expression by DNA-
binding-dependent as well as -independent mechanisms. In line with this, disruption 
of glucocorticoid signalling by germline inactivation of the GR gene in the mouse 
leads to respiratory failure and postnatal lethality. Intriguingly, mice carrying a point 
mutation which selectively impairs homodimeric binding of GR to its cognate 
response elements survive, indicating that the essential functions of GR during 
murine lung development are mediated via protein-protein interactions rather than 
DNA-binding. 
To further elucidate the modes of GR action which mediate these critical effects, 
conditional gene inactivation was employed taking advantage of the Cre/loxP 
recombination system. A series of mutant mice was generated, lacking GR in the 
mesenchyme, endothelial cells or the lung epithelium, respectively, allowing the 
assessment of the relative contribution of these compartments to the phenotype of 
the germline mutation. 
The beneficial effects of corticosteroids have commonly been attributed to their ability 
to induce the functional maturation of lung epithelial cells including the stimulation of 
surfactant synthesis as well as sodium and water transport across the epithelium. 
However, conditional inactivation of the GR gene in all epithelial cells of the 
developing lung did not impair survival. Although these mutant mice displayed a 
delayed progression through the late phases of lung maturation, this retardation did 
not affect respiratory function at birth and was compensated during the first days of 
life or an artificially prolonged pregnancy. 
In contrast, mice lacking GR specifically in mesenchymal cells displayed a 
morphogenetic phenotype strongly reminiscent of GR knockout animals and 
succumbed to death immediately after birth. Comparable to the germline mutants, 
lungs of mutant embryos did not proceed through the canalicular and saccular 
phases of pulmonary development but remained in the pseudoglandular stage until 
birth. At E18.5, they were characterized by cuboidal epithelial cells and an expansion 
of the mesenchymal compartment resulting in an almost complete lack of 
presumptive alveolar airspace. Mutant lungs showed an increased proliferation rate 
and failed to induce general differentiation markers such as p21cip1. Moreover, the 
mutation significantly altered the composition of the extracellular matrix which is 
known to be critical not only as a structural support but also for mesenchymal-
epithelial interactions. 
Finally, endothelium-specific inactivation of the GR gene neither affected postnatal 
survival nor morphogenetic development of the lung precluding an important function 
of GR in endothelial cells during the development of the pulmonary vasculature. 
In summary, the present study demonstrates that GR in the developing murine lung 
epithelium is not essential for postnatal survival. Instead, critical glucocorticoid effects 
are mediated by GR action in the mesenchyme which is necessary to promote 
complete progression through the maturational phases of murine lung development. 
GR acts particularly in cells of the fibroblast lineage where it controls the composition 
of the extracellular matrix and is indispensible for the decrease in the general 
proliferation rate.  
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2. Zusammenfassung 
Eine Vielzahl von Studien sowohl an Menschen als auch an Tieren hat gezeigt, dass 
Glucocorticoide eine zentrale Rolle in der prä- und postnatalen Lungenreifung ausüben. 
Daher gehört die Behandlung mit Corticoiden zur Standardtherapie frühgeborener Kinder 
und hat dazu beigetragen, Vorkommen und Ausmaß der wichtigsten Komplikationen zu 
verringern, der respiratorischen Insuffizienz sowie der bronchopulmonalen Dysplasie. 
Glucocorticoideffekte werden durch den Glucocorticoidrezeptor (GR) vermittelt, der als 
ligandengesteuerter Transkriptionsfaktor die Expression von Zielgenen über Mechanismen 
kontrolliert, die DNA-bindungsabhängig aber auch DNA-bindungsunabhängig sein können. 
In Übereinstimmung damit führt eine Blockade des Glucocorticoid-Signalwegs durch 
gezielte Inaktivierung des GRs in der Maus zu Atemversagen und postnataler Lethalität. 
Interessanterweise überleben Mäuse mit einer Punktmutation, die selektiv die Bindung von 
GR als Homodimer an seine entsprechenden responsiven DNA-Elemente verhindert, was 
darauf hindeutet, dass die wesentlichen Funktionen des GR in der Lungenentwicklung 
über Protein-Protein-Wechselwirkungen ausgeübt werden. 
Um die Wirkungsweisen des GR, die diese essentiellen Effekte vermitteln, näher zu 
untersuchen, wurde das Cre/loxP Rekombinationssystem zur gewebs- und/oder 
zelltypspezifischen Geninaktivierung angewandt. Es wurde eine Reihe von Mausmutanten 
generiert, denen GR entweder im Mesenchym, endothelialen Zellen oder dem 
Lungenepithel fehlt. Dies ermöglicht eine Einschätzung, inwiefern diese Kompartimente für 
den Phänotyp der Keimbahnmutante verantwortlich sind.  
Die positiven Effekte der Corticosteroide wurden gemeinhin ihrer Fähigkeit zugesprochen, 
Aspekte der funktionellen Reifung von Lungenepithelzellen zu induzieren wie die Synthese 
von Surfactant und den transepithelialen Transport von Natrium und Wasser. Eine 
konditionale Inaktivierung des GR-Gens in epithelialen Zellen der fötalen Lunge führte 
jedoch zu keiner Beeinträchtigung der Überlebensrate. Obwohl diese Mausmutanten eine 
Verzögerung der späten Phasen der Lungenreifung aufwiesen, hatte dies keinen Einfluss 
auf die Atemfunktion nach der Geburt und konnte in den ersten Lebenstagen oder durch 
eine künstlich verlängerte Schwangerschaft ausgeglichen werden. 
Im Gegensatz dazu starben Mäuse mit einer mesenchymspezifischen Inaktivierung des 
GR-Gens sofort nach der Geburt und äußerten einen Phänotyp, der in weiten Teilen mit 
dem der GR Knockouttiere übereinstimmt. Die Lungen dieser Mutanten verblieben bis zur 
Geburt in der Pseudoglandulären Phase der Lungenentwicklung und durchliefen weder die 
Kanalikuläre noch die Sakkuläre Phase. Am Tag E18.5 waren sie durch kuboidale 
Epithelzellen sowie eine Zunahme des mesenchymalen Kompartiments charakterisiert, 
was ein praktisch vollständiges Fehlen von zukünftigem alveolärem Luftraum zur Folge 
hatte. Die Lungen der Mausmutanten wiesen eine erhöhte Proliferationsrate auf und die 
Induktion von allgemeinen Differenzierungsmarkern wie p21cip1 blieb aus. Darüber hinaus 
bewirkte die Mutation eine signifikant veränderte Zusammensetzung der 
Extrazellulärmatrix, die zum einen als strukturelles Gerüst dient aber auch in der Lage ist, 
mesenchymal-epitheliale Interaktionen zu beeinflussen. 
Schließlich beeinträchtigte eine endothelspezifische Inaktivierung des GR-Gens weder die 
postnatale Überlebensrate noch die morphogenetische Entwicklung der Lunge, was eine 
entscheidende Rolle des GR in Endothelzellen während der Entwicklung des pulmonalen 
Gefäßsystems ausschließt. 
Zusammenfassend zeigt die vorliegende Arbeit, dass der GR im Epithel der Mauslunge 
für das Überleben nach der Geburt nicht essentiell ist. Im Gegensatz dazu vermittelt der 
mesenchymale GR Glucocorticoideffekte, die unabdingbar sind, um ein vollständiges 
Durchlaufen der Reifungsphase der Lungenentwicklung der Maus zu ermöglichen. GR 
wirkt spezifisch in Fibroblasten, wo er die Zusammensetzung der Extrazellulärmatrix 
kontrolliert und unabkömmlich ist, um die allgemeine Proliferationsrate zu reduzieren. 
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3. Introduction 
 
Successful transition to air-breathing at birth strictly depends on the adequate 
functional maturation of the respiratory system in utero. Accordingly, fetal lung 
development is a complex and highly regulated process orchestrating branching 
morphogenesis, growth and differentiation to ultimately provide the extensive gas 
exchange area critical for postnatal survival. This requires an appropriate spatio-
temporal activity of a large number of regulatory molecules and pathways, including 
glucocorticoids which act via the glucocorticoid receptor (GR) (Bourbon et al., 2005; 
Cardoso and Lu, 2006). 
A vast body of evidence illustrates the fundamental role of glucocorticoid signalling 
during lung maturation in humans as well as rodents (Whitsett and Matsuzaki, 2006). 
While treatment with corticosteroids is accepted and widely employed as standard 
regimen for preterm infants, the precise mechanisms of glucocorticoid action remain 
elusive (Gilstrap et al., 1995).  
 
 
3.1. Development and structure of the murine respiratory system 
 
3.1.1. Lung morphogenesis 
Murine lung development is initiated at embryonic day E9.5 and is commonly divided 
into four stages, the pseudoglandular, canalicular, saccular and alveolar phase 
(Bourbon et al., 2005; Warburton et al., 2005). 
Formation of the respiratory tube starts with the evagination of endodermal cells from 
the anterior foregut into the surrounding mesenchyme (E9.5). The following 
pseudoglandular phase is characterized by growth and repeated dichotomous 
branching of this lung bud giving rise to bronchioles, respiratory bronchioles and 
alveolar ducts. As this respiratory tree evolves, one left and four right lung lobes are 
formed.  
During the canalicular phase of lung development (E16.5 to E17.5), branching 
morphogenesis is completed, and the rapid growth rate diminishes to allow the 
transition to epithelial differentiation. This coincides with the maturation of the 
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Figure 1: Phases of murine lung development 
The pseudoglandular phase starts at E9.5 with the formation of the lung bud and is characterized by 
growth and dichotomous branching of the respiratory tube. With the onset of the canalicular phase at 
E16.5, branching morphogenesis seizes and alveolar dilation is initiated. During the saccular phase 
from E17.5 to birth, terminal differentiation occurs, the epithelium matures and forms close contact with 
the vascular system while the alveolar septae are attenuated. These processes continue until P5 in the 
alveolar phase when in addition secondary septae are formed. 
primitive vascular and capillary network, which surrounds the respiratory tree and is 
formed in parallel with it.  
From E17.5 to birth, terminal differentiation occurs in the saccular phase of murine 
lung development. The distal epithelium matures and becomes composed of alveolar 
type I and type II cells, it flattens and gets in close apposition with the underlying 
vascular system to form the alveolar gas exchange unit. In parallel, the presumptive 
alveoli expand while the mesenchymal stroma in the alveolar septae attenuates.  
During the alveolar phase from birth to postnatal day 5, the interalveolar septae 
become progressively thinner and the initial double capillary layer fuses to the single 
layer of the adult lung. Moreover, secondary septae are formed as low ridges that 
protrude into the primitive airspace and increase the lung surface area.  
 
3.1.2. Cell types of the developing and mature distal lung and their functions 
The mature alveolar epithelium is mainly constituted of alveolar type I and type II 
cells (ATI and ATII). Even though both cell types are found with the same frequency, 
ATI cells cover about 95% of the alveolar epithelial surface. They are highly 
attenuated and form the interface between the luminal airspace and the endothelial 
cells of the pulmonary capillary system. While the basic function of ATI cells is to 
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allow and facilitate efficient gas exchange, ATII cells synthesize and secrete 
pulmonary surfactant, control the ion and fluid transport across the epithelium and 
are involved in the innate immune response. Moreover, they represent a pool of 
progenitor cells differentiating into ATI and other cell types when activated during 
repair and regeneration processes. 
Pulmonary surfactant is a phospholipid-rich lipoprotein consisting primarily of 
phosphatidylcholine and dipalmitoylphosphatidylcholine on the one side as well as 
surfactant-associated proteins (SP)-A, SP-B, SP-C and SP-D on the other side 
(Mendelson, 2000). Produced by columnar ATII cells, surfactant is stored in vesicles 
termed lamellar bodies, and upon secretion into the alveolar lumen, it forms a 
monolayer surface film which serves to reduce surface tension, increase compliance, 
and prevent alveolar collapse (Lewis and Veldhuizen, 2003). In addition, surfactant-
associated proteins have also been attributed with roles in the immune defence 
within the alveolus as well as during the initiation of birth (Condon et al., 2004; 
Wright, 2005).  
In the developing lung, the epithelium of the respiratory tube is composed of 
precursor cells which resemble ATII cells due to their columnar appearance and the 
expression of proSP-C. The mesenchyme is derived from the splanchnic mesoderm 
and gives rise to a wide range of cell types including endothelial progenitors, 
lipofibroblasts, smooth muscle cells and alveolar myofibroblasts (McGowan and 
Torday, 1997).  
 
3.1.3. Epithelial-mesenchymal interactions in the developing lung 
Growth, morphogenic patterning and cellular differentiation in the developing lung 
depend on interactive signalling between the endodermal epithelium and 
mesenchyme derived from splanchnic mesoderm (Shannon and Hyatt, 2004). The 
best characterized model of epithelial-mesenchymal interactions in the developing 
lung is the integrative regulation of branching morphogenesis involving a number of 
signalling molecules: Fibroblast growth factor 10 (FGF10) is expressed in the distal 
mesenchyme and promotes directed growth of the primitive lung bud through 
induction of proliferation and chemotaxis towards the subpleural source (Bellusci et 
al., 1997b; Ramasamy et al., 2007). This stimulatory effect is enhanced by FGF10-
induced expression of bone morphogenic protein 4 (BMP4) in the epithelium and the 
sub-epithelial mesenchyme (Bellusci et al., 1996; Weaver et al., 1999). During 
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elongation of the respiratory tube, epithelial expression of the factors sprouty-2 
(SPRY2) and sonic hedgehog (SHH) block ectopic bud formation through local 
inhibition of FGF signalling in the lateral epithelium and mesenchyme, respectively 
(Bellusci et al., 1997a; Ding et al., 2007).  
Initiation of branching occurs when the proliferation at the tip seizes due to increased 
WNT (wingless related MMTV integration site) and SHH signalling which oppose the 
action of FGF10 (Li et al., 2005a). This coincides with the deposition of fibronectin 
and other components of the extracellular matrix (ECM) at the tip acting as a physical 
block as well as by reducing growth factor availability at the presumptive cleft (Sakai 
et al., 2003). As a consequence, new buds form laterally and proliferate again 
towards the FGF10 sources in the sub-pleural mesenchyme. Epithelial expression of 
the secreted WNT inhibitor dickkopf-1 (Dkk1) restricts fibronectin deposition to the 
cleft by counteracting WNT activity at the new growth tips (De Langhe et al., 2005). 
 
3.1.4. Glucocorticoid action during lung development 
Among the numerous regulatory signalling molecules known to be involved in lung 
development, glucocorticoids belong to the most prominent ones. Initial experiments 
were performed already in 1969 by Liggins demonstrating that corticosteroid 
treatment of fetal lambs accelerates lung maturation (Liggins, 1969). The clinical 
benefit of glucocorticoids for the treatment of preterm infants was then confirmed 
three years later and it has since then served as an important therapy for the 
reduction of morbidity and mortality in these children (Liggins and Howie, 1972). It 
has been shown that incidence and severity of the major complications, respiratory 
distress syndrome (RDS) and bronchopulmonary dysplasia (BPD), are reduced by 
prenatal exposure to pharmacological doses of glucocorticoids resulting in increased 
perinatal survival (Sinclair, 1995). As a consequence, the “US National Institute of 
Health Consensus Developmental Panel on the Effect of Corticosteroids for Fetal 
Maturation on Perinatal Outcomes” strongly recommends the application of prenatal 
glucocorticoids for the treatment of woman at risk for preterm delivery (Gilstrap et al., 
1995). While this therapy is now accepted as standard of care, it is known to have 
also harmful side-effects on other organs like the brain and thus, further refinement of 
indications, timing, dose and duration of glucocorticoid treatment for the prevention or 
treatment of lung disease in the pre- and postnatal period is warranted (Halliday, 
2004). 
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3.2. Glucocorticoids 
 
3.2.1. Glucocorticoid synthesis and its regulation via the hypothalamic-
pituitary-adrenal axis 
Glucocorticoids belong to the family of steroid hormones and are synthesized in the 
zona fasciculata and the zona reticularis of the adrenal cortex. Chemically, they are 
derivatives of cholesterol and as such characterized by a sterane ring system. 
Because of their common origin in the adrenal cortex and similar modes of action, 
they are grouped together with the mineralocorticoids under the denotation 
corticosteroids. In rodents, corticosterone represents the major glucocorticoid while in 
humans it is cortisone. Due to their lipophilic character, corticosteroids are not stored 
but directly released to the circulation where they are preferentially bound to their 
main transport protein called corticosteroid binding globulin or transcortin (Klieber et 
al., 2007).  
Synthesis and levels of circulating corticosterone are tightly controlled by the 
hypothalamic-pituitary-adrenal (HPA) axis (Herman et al., 2003). The paraventricular 
nucleus of the hypothalamus integrates signals from the hippocampus and the 
amygdala and releases corticotropin releasing hormone (CRH) as well as arginine 
vasopressin (AVP). Via the portal blood system, these polypeptides are transported 
to corticotroph cells in the anterior lobe of the pituitary where they induce the 
expression of proopiomelanocortin (POMC). Apart from POMC synthesis, CRH and 
AVP also stimulate the secretion of the adrenocorticotropic hormone (ACTH) which is 
one of the POMC cleavage products. Through binding to its cognate receptors in the 
adrenal cortex, ACTH finally induces synthesis and release of corticosterone.  
Apart from its primary action on other target tissues, circulating corticosterone 
mediates a negative feedback loop on both levels, secretion of CRH as well as ACTH 
in the hypothalamus and the pituitary, respectively (Herbert et al., 2006). The limbic 
structures which control the basal activity of the HPA axis additionally also influence 
this feedback inhibition. Studies using lesioning and electrical stimulation suggest an 
overall inhibitory effect of the hippocampus (Jacobson and Sapolsky, 1991), while the 
amygdala appears to have an excitatory influence (Herman et al., 2003). 
The tone of the HPA axis displays a circadian rhythm which reflects the physiologic 
cycle of activity throughout the day. In nocturnal rodents, high glucocorticoid levels 
 7
  Introduction 
Figure 2: Schematic representation of the regulatory circuit of the hypothalamic-pituitary-
adrenal (HPA) axis 
Activation of the hypothalamic-pituitary-adrenal (HPA) axis is initiated with the release of the 
corticotropin-releasing hormone (CRH) from the hypothalamus, which activates the synthesis of 
proopiomelanocortin (POMC) in the adenohypophysis. POMC is processed into the 
adrenocorticotropic hormone (ACTH) which is released from the anterior lobe of the pituitary and 
activates synthesis and secretion of corticosterone in the adrenal cortex. Corticosterone-bound GR 
mediates the direct negative feedback at the level of the pituitary and hypothalamus, resulting in the 
return to homeostasis. Activated GR and MR in limbic structures like the hippocampus and amygdala 
control the tone of the HPA axis. 
coincide with the beginning of the dark phase, whereas the HPA axis is most active 
at the beginning of the light phase in diurnal humans. Accordingly, the resting phase 
is paralleled by low levels of corticosteroids, respectively, and thus represents the 
circadian trough.  
During murine embryonic development, glucocorticoid synthesis is initiated at E14.5 
but the levels remain low until a tremendous surge is observed towards term. Starting 
at E16.5, the corticosterone levels strongly increase and reach their maximum 
between E18.5 and birth before they return to low levels during the first days after 
birth.  
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3.2.2. Glucocorticoid mediated effects 
Apart from their role during embryonic lung development, glucocorticoids exert 
pleiotropic functions and play a pivotal role in the maintenance of homeostasis in 
mammalian organisms. As a consequence, dysregulation of the HPA axis and 
malfunction of glucocorticoid signalling are associated with certain pathophysiological 
circumstances. On the other hand and despite considerable side effects, 
corticosteroid therapy allows the treatment and/or alleviation of a wide variety of 
diseases. 
Insufficient production of glucocorticoids by the adrenal cortex leads to Addison’s 
disease, characterized by metabolic imbalances and disturbed fluid and salt 
homeostasis but also disorders of the central nervous system (Ten et al., 2001). In 
contrast, Cushing’s disease describes the symptoms associated with increased 
glucocorticoid levels: for instance a catabolic shift with reduced glucose tolerance, 
osteoporosis, and muscular atrophy due to increased proteolysis, redistribution of 
adipose tissue with consequent central obesity, hypertension and atherosclerosis as 
well as repression of the immune system (Krieger, 1983). 
In general, glucocorticoids are the principal mediators of stress responses to external 
stressors such as predators or infections, but also internal imbalances for instance in 
energy or fluid homeostasis. Hence, glucocorticoids are well known for their role in 
the metabolic regulation where they generally exert catabolic and anti-insulinergic 
effects with the exception of the liver (Vegiopoulos and Herzig, 2007). 
Glucocorticoids increase blood glucose levels by inhibiting cellular uptake and 
utilization of glucose in peripheral organs and stimulate in particular hepatic 
gluconeogenesis as well as glycogen synthesis (Pilkis and Granner, 1992). They also 
induce proteolysis in the musculature, lymphatic tissue, skin and bones providing free 
amino acids to sustain gluconeogenesis in the liver (Schacke et al., 2002). In 
adipocytes, glucocorticoids inhibit the uptake of glucose and stimulate lipolysis, thus 
increasing the availability of free fatty acids (Simmons et al., 1984). Many 
glucocorticoid effects are mediated via a direct transcriptional control of regulatory 
enzymes, for example in the case of the phosphoenolpyruvate-carboxykinase or the 
tyrosine aminotransferase (Hanson and Reshef, 1997; Jantzen et al., 1987; Schmid 
et al., 1985). However, it is noteworthy that some of those actions such as enhanced 
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lipolysis are only permissive, allowing and/or increasing the effects of other signalling 
molecules such as glucagon or catecholamines (Pilkis and Granner, 1992). 
Other very crucial effects of glucocorticoids are the suppression of the immune 
system and the inhibition of inflammational reactions which are the basis for their 
widespread and valuable clinical application (Barnes and Adcock, 1993; Calandra et 
al., 1995). They repress the expression as well as secretion of a variety of cytokines 
and block histamine release, leading among others to the inhibition of T-cell 
proliferation (Vacca et al., 1992). Glucocorticoids were shown to act pro-apoptotic in 
T-lymphocytes (Khan et al., 1996; Thompson, 1994) and chronically elevated 
glucocorticoid levels result in a regression of thymus size in mice (Tronche et al., 
1998). 
Extensive progress has also been made in the understanding of glucocorticoid 
actions in the central nervous system. Among the various influenced processes are 
neuronal excitability and plasticity, neurogenesis and neuronal cell death as well as 
neuroendocrine control and behavioural responses like learning, memory and anxiety 
(De Kloet et al., 1998; Herbert et al., 2006). In addition, research both in humans and 
in animal models has implicated the forebrain GR in depression (Calfa et al., 2003; 
Gass et al., 2001). In animal models of depression it was shown that a depression-
like phenotype is associated with decreased hippocampal GR expression (Boyle et 
al., 2005; Ridder et al., 2005). 
 
 
3.3. The glucocorticoid receptor 
 
3.3.1. Corticosteroid receptors 
The effects of the two corticosteroid hormones corticosterone and aldosterone are 
mediated by two closely related steroid hormone receptors, the glucocorticoid 
receptor (GR) and the mineralocorticoid receptor (MR). GR and MR belong to the 
superfamily of ligand-activated transcription factors including other steroid receptors 
such as the estrogen or androgen receptor but also receptors for vitamin D3, retinoic 
acid and thyroids as well as orphan receptors (Beato and Klug, 2000; Mangelsdorf et 
al., 1995). Cloning and sequencing of the genes for GR (NR3C1) (Hollenberg et al., 
1985; Miesfeld et al., 1986) and MR (NR3C2) (Arriza et al., 1987; Patel et al., 1989) 
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revealed a high degree of homology and allowed analysis of their binding activities 
and expression pattern.  
While GR shows a very widespread expression and is found in almost every cell, 
prominent sites of glucocorticoid action are the liver, the lung, the brain and the 
immune system (Cole et al., 1993). In contrast, MR expression is much more 
restricted and predominantly found in the distal segments of the renal tubuli but also 
in the colon, the sweat and salivary glands and certain structures of the brain (Arriza 
et al., 1988; Zennaro et al., 1997). 
Although both receptors are able to bind each of the two ligands, GR binds 
corticosterone (KD ~ 5nM) with a tenfold higher affinity than aldosterone (KD ~ 50nM) 
(Funder, 1992). Therefore, GR is expected to be occupied predominantly by 
glucocorticoids under physiological circumstances due to the considerably higher 
plasma concentration of corticosterone (0.5-50nM) compared to aldosterone (0.1-
0.5nM).  
In contrast, MR shows similar affinities for both corticosteroids (KD ~0.5nM) and the 
affinity of MR for glucocorticoids is about one order of magnitude higher than that of 
GR to its preferred ligand corticosterone. Thus, MR does not exhibit intrinsic 
specificity for aldosterone but is protected by a pre-receptor mechanism from the 
higher plasma glucocorticoid levels. To allow exclusive mineralocorticoid activity, 
aldosterone target tissues such as the distal segments of the renal tubuli or the colon 
express the enzyme 11β-hydroxysteroid-dehydrogenase type 2 (11βHSD2) which 
converts corticosterone into the receptor-inactive 11-dehydrocorticosterone (Albiston 
et al., 1994; Funder et al., 1988). 
 
3.3.2. Functional domains of the glucocorticoid receptor 
Similar to other nuclear receptors, the GR as well as its close homologue MR are 
composed of several domains and subdomains, depicted in Figure 3. For the 
corticosteroid receptors, six different domains were described and denoted A to F 
from the aminoterminal to the carboxyterminal end. Three major functional units can 
be classified: the aminoterminal transactivation domain AF1 (TAD), the DNA-binding 
domain (DBD) and the carboxyterminal ligand-binding domain (LBD) (Beato et al., 
1995; Beato and Klug, 2000).  
The AF1 domain comprises the domains A and B and is a ligand-independent, 
constitutive activation domain. The transactivation domain performs specific 
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Figure 3: Functional domains of the glucocorticoid receptor 
The GR gene comprises nine exons. Exon 2 contains the start codon (ATG) and encodes the domain 
A/B which forms the aminoterminal transactivation domain (TAD). Exons 3 and 4 encode the DNA 
binding domain (domain C, DBD) containing two zinc finger motifs and the dimerization domain. The 
hinge domain (D) connects the DBD with the ligand-binding domain (domain E, LBD) encoded by 
exons 5 to 9. Nuclear localization sequences are found in domain D and E and the LBD contains a 
second transactivation as well as a second dimerization domain. 
interactions with other transcription factors and components of the basal transcription 
machinery allowing promotor and cell type-specific activation of receptor-mediated 
transcription. 
The central DBD (domain C) consists of two zinc finger motifs characterized by a zinc 
ion which is complexed by four cystein residues (Luisi et al., 1991; Umesono and 
Evans, 1989). The DBD recognizes and binds to specific palindromic DNA sequence 
motifs, called glucocorticoid response element (GRE). The aminoterminal zinc finger 
has been shown to define the hormone response element recognized by the receptor 
since replacement by the zinc finger of another steroid hormone receptor changes 
the specificity of DNA binding (Green et al., 1988). The crystal structure of the GR 
DNA-binding domain bound to DNA revealed that three specific amino acids within 
one α-helix of the first zinc finger form the P-box which provides DNA sequence-
specific binding to the GRE in the major groove of the DNA helix (Mader et al., 1989). 
The second zinc finger binds non-specifically to the minor groove of the DNA helix 
stabilizing the interaction of the DBD with the GRE. Moreover, it harbours the D-box 
comprised of five amino acids which are important for the formation of GR 
homodimers and thus cooperative high affinity binding of GR dimers at the GRE 
(Beato, 1989; Luisi et al., 1991). The hinge region (domain D) connects the DBD with 
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the LBD, contains a nuclear localization sequence and mediates conformational 
changes of the steroid hormone receptors upon ligand binding. 
The carboxyterminal LBD (domain E) forms a pocket with the ligand binding site 
which provides the specificity and selectivity of steroid hormone binding. In addition, 
it contains a ligand-dependent transactivation domain and sequences important for 
dimerization and nuclear localization as well as interactions with either chaperones or 
other transcription factors (Beato and Klug, 2000). No specific function has been 
described for domain F so far. 
 
3.3.3. Molecular action of the glucocorticoid receptor 
Due to their lipophilic character, glucocorticoids diffuse freely through the cell 
membrane to the cytosol where they bind to GR. In the absence of the ligand, the 
receptor is part of a large heteromeric complex which prevents it from entering the 
nucleus but also supports an optimal conformation for high-affinity ligand binding 
(Morishima et al., 2003; Pratt and Toft, 2003). A number of chaperones and cofactors 
participate in the formation of this complex, for instance hsp90, hsp70, Imunophilins, 
FKBPs, CyP-40 and p23 (Gehring, 1993; Pratt and Toft, 1997). Binding of the 
hormone induces a conformational change of the receptor resulting in dissociation of 
the receptor from the protein complex and exposure of the nuclear localization 
sequences, the dimerization domains and the DNA binding domain. This activated 
state of the receptor allows importin α and β to mediate translocation into the nucleus 
where GR binds to GREs within the regulatory regions of target genes (Freedman 
and Yamamoto, 2004). The glucocorticoid, mineralocorticoid, progesterone and 
androgen receptors all recognize the identical DNA sequence, which does therefore 
not confer specificity of the hormone response. The consensus sequence for dimeric 
high-affinity binding of the receptors is a palindromic 15bp sequence 
(GGRACAnnnTGTYCT, where Y is a pyrimidine and R a purine base). Once bound 
to its response element, GR interacts with the basal transcription machinery and 
various cofactors to enhance the expression of the regulated gene. 
Apart from this classical direct transactivation activity as a homodimer, GR can also 
participate in the regulation of target genes by multiple modes of interaction with 
other transcription factors. According to the molecular mechanisms involved the 
following types of interactions can be distinguished: 
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First, composite response elements bind both, GR and another transcription factor, 
leading to crosstalk which may be positive or negative. For example, GR and cAMP 
response element binding protein (CREB) co-operate on the promotor of the 
phosphoenolpyruvate-carboxykinase, mutually enhancing their binding and 
transactivation activity (Imai et al., 1993). Adding another level of complexity, the 
result of GR interaction with the dimeric transcription factor AP-1 in some cases 
depends on the particular subunit composition: While it enhances the transcriptional 
activation of c-Jun homodimers on the mouse proliferin gene, GR represses the 
induction of the same gene by c-Jun/c-Fos heterodimers (Diamond et al., 1990). 
In the second case of overlapping response elements, transcription factor binding 
sites share common sequences and thus, binding of one factor precludes the 
interaction of the other with its cognate binding site. GR-mediated repression of the 
osteocalcin gene by blocking the interaction of TFIID of the general transcription 
machinery with the TATA box is one example for this mode of action (Stromstedt et 
al., 1991). 
Third, according to the tethering mechanism, GR modulates gene expression 
independent from DNA-binding by interacting with another transcription factor which 
is bound to DNA or vice versa. In most cases, this crosstalk results in repression and 
has therefore been named trans-repression. For instance, GR blocks AP-1-
dependent induction of the genes for collagenase 1 and 3 (Kassel et al., 2004; 
Rogatsky et al., 2001) while AP-1 has also been described to inhibit GR-mediated 
transactivation on promotors containing only GREs (Schule et al., 1990). Similar 
observations were made for a number of other transcription factors such as NF-κB, 
Smad3 and 4, IRF3, PU.1/Spi1 or COUP-TFII (De Martino et al., 2004; Gauthier et 
al., 1993; Luecke and Yamamoto, 2005; Reily et al., 2006; Song et al., 1999). 
Nevertheless, co-operation of GR and Stat5 exemplifies that tethering interactions 
can result in positive synergistic action as well. Recently, the in vivo relevance of this 
mechanism has been demonstrated in mice lacking GR and/or Stat5 specifically in 
the liver. A subset of hepatic Stat5 target genes strictly depends on GR-Stat5 
interaction and this positive crosstalk was shown to be indispensible for normal 
postnatal growth (Engblom et al., 2007). 
Finally, interaction of GR with other transcription factors can also be independent 
from DNA binding and lead to sequestration of both factors away from their 
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respective binding sites or even to the proteasome as in the case of GR and p53 
(Sengupta et al., 2000; Sengupta and Wasylyk, 2001). 
Although GR and MR both bind glucocorticoids under physiological conditions and 
recognize the same HREs, they are able to elicit receptor-specific responses by 
differential interaction with additional transcription factors (Arriza et al., 1988; 
Rupprecht et al., 1993). Thus, the specificity of GR transactivation activity depends 
on the individual combination of transcription factor binding sites in the 
promotor/enhancer elements of target genes as well as the differential and cell type-
specific expression of the interacting transcription factors (Pearce and Yamamoto, 
1993). 
 
3.4. Analysis of GR function in vivo 
3.4.1. GR mutant mice 
Many initial studies of GR function relied either on pharmacologic interference with 
the receptor or adrenalectomy with subsequent hormone replacement. However, 
antagonists often provide only incomplete blockade and the implication of unspecific 
effects is difficult to exclude. Adrenalectomy, on the other side, removes in addition to 
glucocorticoids also mineralocorticoids and catecholamines, thus impairing direct 
association of the observed effects with GR function only. To circumvent these 
caveats, mouse models were implemented which took advantage of genetic 
inactivation of the GR gene. 
Two distinct mutations leading to germ-line inactivation of the GR gene have been 
reported. The first approach targeting exon 2 was later shown to allow the expression 
of a truncated protein due to alternative splicing and this allele was therefore termed 
hypomorphic (Cole et al., 1995; Mittelstadt and Ashwell, 2003). The null allele, in 
contrast, was generated by deletion of exon 3 and results in complete ablation of GR 
protein expression overcoming the incomplete penetrance observed in the 
hypomorphic allele (Tronche et al., 1998). 
Mutant mice homozygous for the hypomorphic or the null allele (GRnull) die shortly 
after birth due to respiratory failure. They manifest a strong dysregulation of the HPA 
axis leading to elevated plasma levels for corticosterone as well as ACTH and 
consequently hyperplasia and hypertrophy of the adrenal cortex. Moreover, the 
hepatic induction of gluconeogenic enzymes was shown to be impaired and GR 
deficient thymocytes were resistant to glucocorticoid-induced apoptosis (Cole et al., 
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1995). In the following, a number of conditional mutants has been generated using 
the Cre/loxP recombination system to analyze specific GR function in adult animals 
(see chapter 3.4.2.). 
Moreover, a function-selective mutation has been established by introducing a point 
mutation into the dimerization domain of GR (GRdim mice). This alteration selectively 
perturbs homodimeric binding of GR to its cognate response elements while the 
modulation of gene expression via protein-protein interaction is preserved (Heck et 
al., 1994). Surprisingly, this mutation did not impair survival highlighting the 
importance of DNA-binding independent GR functions (Reichardt et al., 1998). 
Whereas established GRE-dependent target genes such as tyrosine 
aminotransferase were non-responsive to glucocorticoid stimulation, important anti-
inflammatory activities mediated by protein-protein interaction were maintained. 
 
3.4.2. Conditional gene inactivation using the Cre/loxP recombination system 
Early lethality of knockout mice and pleiotropic functions in different organs have 
complicated the analysis of gene function in the adult organism in the case of the GR 
but also a number of other genes. The two components of the Cre/loxP 
recombination system allow inactivation of a gene of interest in a cell type- or tissue-
specific manner (Figure 4A). First described in P1 bacteriophages, it employs the Cre 
recombinase which recognizes and mediates recombination of DNA molecules 
containing specific palindromic motifs called loxP sites (Gu et al., 1994). The flanking 
of an essential part of the gene of interest with these loxP sites in the same direction 
allows Cre-mediated recombination and hence gene inactivation. Cell type-specific 
ablation of a desired gene is achieved by the expression of the Cre recombinase 
under control of specific regulatory elements (Nagy, 2000). 
More recently, this system has been further advanced by the development of a fusion 
protein of the Cre recombinase with a mutated ligand binding domain of the estradiol 
receptor (CreERT2; Figure 4B). The latter retains the fusion protein in the cytoplasm, 
and only upon binding of the synthetic ligand tamoxifen it translocates into the 
nucleus, where it mediates the excision of the loxP-flanked DNA sequence (Feil et 
al., 1997; Kellendonk et al., 1999; Kellendonk et al., 1996; Weber et al., 2001). 
Appropriate application of tamoxifen in combination with specific regulatory elements 
to control Cre expression allows not only cell type-specific but also inducible 
inactivation of the gene of interest. 
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In the case of the conditional GR allele (GRflox), exon 3 encoding the first zinc finger 
of the DNA binding domain has been flanked by loxP sites. Importantly, GR 
expression remains unaffected in the absence of the recombinase whereas Cre-
mediated excision results, if splicing occurs from exon 2 to exon 4, in a frame shift of 
the coding sequence which results in ablation of GR protein expresion (Berger et al., 
2006; Tronche et al., 1999). 
Originally, short promotor/enhancer fragments of genes with desired expression 
pattern have been cloned in front of a Cre cassette to drive the expression of the Cre 
recombinase (Mantamadiotis et al., 2002; Tronche et al., 1999; Tsien et al., 1996). 
However, these plasmid-derived transgenes often show copy number-independent, 
mosaic or ectopic expression (Otto et al., 2001; Shimshek et al., 2005). Since the 
development of the recombineering technology, the use of BAC (bacterial artificial 
chromosome)- or YAC (yeast artificial chromosome)-derived transgenes has 
therefore become the method of choice (Copeland et al., 2001; Lee et al., 2001; 
Muyrers et al., 1999; Zhang et al., 1998). In contrast to plasmids, these vectors 
harbor large genomic regions containing almost all regulatory elements of the gene 
locus that was chosen to drive Cre expression. Accordingly, this results in faithful cell 
type-specific and copy number-dependent Cre expression (Muyrers et al., 1999; 
Schedl et al., 1993b). 
Further illustrating the pleiotropic functions of this receptor, conditional GR mutants 
have been employed in a variety of studies. Mice with prenatal onset of GR 
deficiency in neurons and glial cells showed a strongly activated HPA axis which 
caused Cushing-like symptoms including altered fat distribution and reduced bone 
density. In addition, the mutant mice displayed reduced anxiety (Tronche et al., 
1999). As mentioned before, mice lacking GR specifically in hepatocytes have been 
used to investigate GR functions in the control of metabolism and postnatal growth 
signalling (Engblom et al., 2007; Tronche et al., 2004). Finally, different cell types of 
the immune system have been targeted leading to advanced understanding of 
glucocorticoid action in inflammation and therapy (Kleiman and Tuckermann, 2007). 
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Figure 4: The Cre/loxP recombination system allows cell type-specific constitutive and 
inducible inactivation of a target gene 
(A) To achieve cell type-specific gene inactivation with the Cre/loxP-recombination system, an 
essential part of a gene has to be flanked by loxP sequences without affecting the expression of the 
gene. The cell type/tissue-specific expression of the Cre recombinase under control of specific 
regulatory elements results in deletion of the loxP-flanked part and thereby in gene inactivation only in 
these Cre-expressing cells. (B) The Cre/loxP-recombination system has been advanced with the 
tamoxifen-inducible fusion protein consisting of the Cre recombinase and the mutated ligand binding 
domain of the human estrogen receptor (CreERT2) to achieve ligand-dependent Cre activity. The 
unliganded form of the CreERT2 fusion protein resides in the cytoplasm and upon tamoxifen binding it 
translocates into the nucleus and mediates site-specific recombination of the loxP-flanked DNA 
sequence.
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3.5. Aim of the thesis 
Clinical application and animal experiments provide ample evidence for an important 
role of the GR-mediated glucocorticoid signalling during murine lung development. In 
line with this, previous studies in our lab showed that mice with a germline 
inactivation of the GR gene die postnatally due to respiratory failure. In contrast, mice 
carrying a point mutation in the GR gene which prevents DNA binding of the receptor 
as a homodimer survive. These findings indicated that the essential functions of GR 
during murine lung development are mediated via protein-protein interactions.  
The aim of the present study was to further elucidate these modes of action using the 
Cre/loxP recombination system for conditional inactivation of the GR gene. To 
identify the cell types mediating the critical glucocorticoid effects during murine lung 
development, a series of mutants was generated lacking GR specifically in the 
mesenchyme, endothelial cells or the lung epithelium, respectively. 
Beneficial effects of corticosteroids for lung maturation have commonly been 
attributed to their ability to induce the functional maturation of lung epithelial cells 
including the synthesis of surfactant. Therefore, we took advantage of a mouse line 
expressing the Cre recombinase under control of a 3.7kb promotor of the human 
Sftpc gene (Spc-Cre) to generate mice lacking GR specifically in lung epithelial cells. 
In the course of these experiments, this mutation was shown not to impair survival of 
the mice, pointing towards an important role of GR in the mesenchyme. To verify this 
assumption, mice lacking GR specifically in mesenchymal cells were generated. This 
was achieved using a transgenic mouse line which expresses the Cre recombinase 
from a BAC containing the regulatory elements of the collagen type (I)-alpha 2 locus. 
To assess the participation of GR in the regulation of vascular development in the 
lung, a Tie2-Cre line was finally employed to inactivate GR specifically in endothelial 
cells. 
The mutant animals were analyzed by a series of methods including histology, 
immunohistochemistry and gene expression profiling to investigate glucocorticoid 
effects in specific cell types. The resulting findings should further contribute to the 
understanding of the mechanisms behind the essential GR effects during lung 
development and may help to identify potential interaction partners. 
 
 
  Results 
 
 
4. Results 
 
4.1. Generation of a lung epithelium-specific Cre line (mSftpc-Cre) 
To allow conditional recombination specifically in lung epithelial cells of the mouse, a 
BAC-derived transgene was generated expressing the codon-improved Cre 
recombinase (Shimshek et al., 2002) under control of the regulatory elements of the 
locus (Figure 5A) 
were confirmed by pulse-field gel electrophoresis as well as Southern Blot 
 identified three 
ice carrying the mSftpc-Cre transgene (Figure 5D). However, none of these was 
able to generate transgenic offspring, thus precluding further analysis as well as any 
application of the mouse line.  
mouse gene for the surfactant-associated protein C (mSftpc). The BAC RP24-
252D18 was selected from the NCBI CloneFinder and contained a genomic insert 
including ~80kb upstream as well as ~80kb downstream of the mSftpc gene. 
Homologous recombination in bacteria was used to insert the sequence encoding the 
Cre recombinase at the ATG into the reading frame of the mSftpc 
(Lee et al., 2001).  
In the applied targeting construct, two homology arms flanked the coding sequence 
of the Cre as well as a cassette containing an ampicillin resistance gene in between 
two FRT recognition sites for the Flp recombinase. At the 3’end of the 5’homology 
arm, the ATG of the mSftpc gene was cloned in frame with the sequence encoding 
the Cre recombinase while the 3’homology arm started at its 5’end with the first intron 
of the mSftpc gene.  
The linearized targeting construct was electroporated into competent bacteria of the 
EL250 strain (Lee et al., 2001) containing the BAC, and clones showing ampicillin 
resistance were analyzed for correct recombination by analytical restriction digestion. 
The ampicillin resistance cassette was subsequently removed by induced expression 
of the Flp recombinase, before the integrity and correct modification of the genomic 
insert 
analysis (Figure 5B). The BAC backbone was removed by NotI digestion, and the 
modified genomic insert was isolated using a gel filtration column (Figure 5C). 
Finally, the construct was introduced into the mouse germline by pronuclear injection 
(Schedl et al., 1993a). 
Analysis of the potentially transgenic progeny by Dot Blot and PCR
m
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Figure 5: Generation of a transgenic mouse line expressing the Cre recombinase from a BAC
containing the mSftpc locus 
A) Using homologous recombination in bacteria, a cassette encoding the Cre recombinase was
inserted in frame with the ATG of the mSftpc gene contained in the BAC RP24-252D18. After 
identification of homologous recombinant clones (mSftpc intermediate) the ampicillin resistance 
cassette was removed by Flp recombination. B) Southern blot was performed to confirm the correct
modification of the BAC using a probe recognizing a sequence in the 3’ homology arm as represented
in A. Band sizes are indica
genomic insert of the BAC
ted and reflect the XhoI fragments depicted in A. C) Subsequently, the 
 was released by NotI digestion and purified on a gel filtration column.
Samples of the fractions were analyzed by pulse field gel electrophoresis and fraction 12 (*) was used
for pronuclear injection. ** and *** mark the sizes of the BAC backbone (~15kb) and the modified
genomic insert (~160kb), respectively. D) Three animals carrying the mSftpc-Cre transgene were 
identified by DotBlot and PCR (insert).  
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Figure 6: The plasmid-based Spc-Cre transgene mediates lung epithelium-specific 
recombination  
A) 3.7kb of the 5’-flanking region of the human Sftpc gene are used to drive Cre expression. B) Faithful 
recombination in the lung epithelium by the Spc-Cre line was verified using whole mount β-
galactosidase staining of E16.5 R26RSpc-Cre lungs. Paraffin sections were prepared of these specimens 
and lightly counterstained with eosin. Prominent blue staining is observed throughout all epithelial 
cells. 
Yet, in the course of these experiments, another lung epithelium-specific Cre line was 
published and became available (Okubo and Hogan, 2004). This transgenic line 
exploits a well characterized 3.7kb promotor of the human Sftpc gene to drive Cre 
expression (Figure 6A) (Glasser et al., 1991; Wert et al., 1993). The Spc-Cre line was 
obtained by Brigid Hogan, and the specific recombination pattern was verified using a 
Rosa26 Cre reporter mouse (Soriano, 1999). This line carries a knock-in of the 
β-galactosidase preceded by a stop cassette in the Rosa26 locus. Since the stop 
cassette is flanked by two loxP sequences, Cre activity results in its excision and 
thereby allows expression of the β-galactosidase. As expected, animals positive for 
the Cre reporter as well as the Spc-Cre transgene showed strong β-galactosidase 
activity in the entire population of lung epithelial cells at all stages analyzed (from 
 
periments to ablate GR in lung epithelial cells. 
vealed the presence of all genotypes with the expected frequency (Figure 7A). This 
E16.5, depicted in Figure 6B, to E18.5, data not shown). Consequently, this line was
employed for all further ex
 
4.2. Lung epithelium-specific loss of GR does not impair survival 
Mice lacking GR specifically in lung epithelial cells were generated using the 
Cre/loxP system. To this end, Spc-Cre mice expressing the Cre recombinase under 
control of the human Sftpc promotor were intercrossed with GRflox animals. 
Genotyping of litters containing GRflox/flox/Spc-Cre (GRSpc-Cre) mice at weaning 
re
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Figure 7: Lung epithelium-specific loss of GR does not impair survival 
A) Genotypical analysis after weaning of offspring containing the genotypes GRflox/flox/Spc-Cre (left 
hand side) or GRflox/null/Spc-Cre (right hand side) - n~50, respectively. The litters contained all expected 
genotypes in mendelian frequencies. B) Immunohistochemistry for GR on 6µm paraffin sections 
demonstrated lung epithelium-specific protein loss in GRSpc-Cre animals. E17.5 lungs of control animals 
showed strong epithelial staining for GR protein (black arrows) compared to lower intensity in the 
mesenchyme (red arrow). In contrast, GRSpc-Cre lungs displayed immunoreactivity only in mesenchymal 
cells (red arrow) while no GR protein was detected in the epithelium (black arrows). 
indicates that inactivation of the GR gene in lung epithelial cells did not impair 
survival.  
To confirm the efficacy of the employed gene ablation system, GR 
onic lungs at 
achieved in epithelial cells of GRSpc-Cre mice. 
immunohistochemistry was performed on paraffin sections from embry
E17.5 when epithelial and mesenchymal cells are easy to distinguish (Figure 7B). As 
expected, control littermates showed strong GR expression in epithelial cells 
compared to lower immunoreactivity in the mesenchyme. In contrast, GR staining 
was absent in the epithelium of GRSpc-Cre mutant mice while expression was 
preserved in mesenchymal cells. Thus, efficient conditional gene inactivation was 
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In an additional attempt to further reduce the GR dosage in the residual GR 
expressing cells of the mesenchyme, mice were generated carrying the Spc-Cre 
transgene in combination with one conditional GRflox and one GRnull allele 
(GRnull/flox/Spc-Cre). GRnull/+/Spc-Cre mice were intercrossed with GRflox/flox animals 
and the resulting litters were genotyped at weaning. PCR analysis revealed that all 
expected genotypes were observed with mendelian frequency, including 
GRnull/flox/Spc-Cre mice (Figure 7A). This demonstrates that even a single intact GR 
allele in the mesenchyme suffices to complete lung development in the absence of 
epithelial GR. 
Figure 8: Lung morphogenesis in GRSpc-Cre embryos 
HE staining of 4.5µm paraffin sections from GRSpc-Cre and control lungs collected at the indicated day. 
Mutant animals show a delay in the tubular dilation as well as the thinning of the alveolar septae and 
are characterized by mesenchymal accumulations at P0. 
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4.3. Lung epithelium-specific loss of GR transiently delays lung maturation 
The effects of lung epithelium-specific inactivation of the GR gene on late lung 
development were further analyzed. Hematoxylin eosin (HE) staining of paraffin 
sections illustrates the morphogenetic progress of GRSpc-Cre lungs compared to those 
of littermate control mice (Figure 8). Mutant animals display less dilated alveolar 
saccules and correspondingly a higher frequency of unexpanded rosettes. At E18.5 
and P0, their lungs are also characterized by a higher incidence of regions with 
mesenchymal accumulation compared to control animals.  
Electron microscopy demonstrates that the thinning of the alveolar septae is 
incomplete in GRSpc-Cre animals at E18.5 resulting in an increased thickness of the 
Figure 9: GRSpc-Cre lungs display increased thickness of the alveolar septae at the expense of
alveolar airspace 
A) Electon microscopy of mutant and control lungs shows an increased thickness of the alveolar 
septae in GRSpc-Cre mice. Nevertheless, the epithelium attenuates and comes in close apposition with
the capillary system (V indicates vessels). Surfactant-containing lamellar bodies are also observed 
alveolar type II cells. B) Morphometric
mi-th  and the percentage of the total area was
ant increase. 
(arrows) indicating proper functional maturation of 
measurements were performed on se in sections
determined for the alveolar, mesenchymal and epithelial compartments. Compared to controls, the 
alveolar compartment is reduced in mutant lungs while the mesenchymal compartment is increased.
The epithelial compartment also shows a small but signific
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alveolar walls (Figure 9A). Finally, morphometric measurements on semi-thin 
he 
tant compared to control 
nature or persistent as incomplete maturation, pregnant mothers were injected with 
progesterone to prolong the pregnancy. Embryos were collected at E20.5 (~1.5 days 
beyond the expected delivery) and lung morphology was analyzed using HE staining 
(Figure 10). GRSpc-Cre lungs were virtually indistinguishable from controls and both 
genotypes demonstrated a progression to the alveolar stage of murine lung 
development. This phase of final alveogenesis is characterized by the formation of 
secondary septae, visible as numerous small protrusions into the alveolar lumen. The 
associated rough appearance is observed in both, mutant and control animals, 
demonstrating that GRSpc-Cre mice overcome their morphogenetic delay and recover 
to normal progression through the final alveolar phase of murine lung development. 
 
sections revealed a significant reduction of the alveolar area at the expense of t
mesenchymal compartment (Figure 9B).  
Nevertheless, these techniques also demonstrated that the functional maturation of 
the alveolar gas exchange unit is not critically impaired in GRSpc-Cre mice. During this 
process, the epithelium flattens and comes in close apposition with the endothelium 
of the underlying capillary system. These findings were additionally substantiated by 
histological examination of differentiation markers such as proSpc, T1α or glycogen 
revealing no significant difference in staining pattern in mu
animals (data not shown). 
To investigate whether the observed retardation in lung development was of transient 
 
Figure 10: A prolonged pregnancy enables GRSpc-Cre embryos to compensate their 
developmental delay  
Pregnancies were artificially prolonged by progesterone treatment. Mutant as well as control lungs
progressed to the alveolar phase of murine lung development, indicated by formation of secondary
septae which are visible as small protrusions into the lumen (arrows).  
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4.4. Inactivation of the GR gene in the mesenchyme leads to postnatal lethality 
The results obtained by lung epithelium-specific inactivation of the GR gene in 
-Cre) offspring. When the litters were genotyped after 
GRSpc-Cre mice indicated an important role of GR in the surrounding mesenchyme for 
fetal pulmonary maturation. In order to determine the contribution of mesenchymal 
GR to murine lung development, we employed a transgenic mouse line expressing 
the Cre recombinase from a BAC containing the locus of the collagen type (I)-alpha 2 
gene (Col1-Cre) (Florin et al., 2004). The Cre transgene has been shown to mediate 
recombination in the mesenchyme and was crossed with GRflox mice to obtain 
GRflox/flox/Col1-Cre (GRCol1
weaning, however, no mutant GRCol1-Cre animals were found pointing towards early 
lethality of these mice. Confirming this assumption, close inspection immediately 
after birth revealed that GRCol1-Cre neonates showed respiratory distress and cyanosis 
leading to death within the first hour of life.  
Since the Col1-Cre transgenic mouse line has occasionally been reported to 
recombine unspecifically in the germline (P. Angel, personal communication) we 
sought to verify that GR was still expressed in non-targeted cells. 
Immunohistochemistry demonstrated persistent GR protein expression in the 
epithelium of P0 lungs from GRCol1-Cre animals which were compared to E17.5 control 
lungs due to their similarity in cellular morphology (Figure 11).  
 
Figure 11: Persistent GR protein expression in epithelial cells of GR  embryos 
6µm paraffin sections were stained with an antibody against d lightly counterstained with 
Col1-Cre
GR an
hematoxylin. Specimen from E17.5 control and P0 mutant embryos were compared due to their 
similarity in morphology. Persistent strong GR staining is observed in the epithelium of mutant lungs 
(arrows). 
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4.5. Loss of mesenchymal GR arrests lung development at the transition from 
the pseudoglandular to the canalicular phase and phenocopies the GR 
knockout mutation 
Histological examination of embryonic lungs from GRCol1-Cre embryos and control 
littermates indicated that earlier lung development and branching morphogenesis 
were unaltered until E16.5 (data not shown). While control lungs subsequently further 
progressed through the canalicular and saccular phase, mutant lungs were still in the 
Figure 12: Lung morphogenesis in GR  embryos 
HE stainings of 4.5µm paraffin sections from mutant and control lungs of the indicated age. Insets
show a lower magnification overview. While control lungs display the normal morphogenetic
developm
oes not dilat
Col1-Cre
ent, mutant lungs remain in the pseudoglandular phase until E18.5. The respiratory tube
e and is lined by immature cuboidal epithelial cells. At birth, GRCol1-Cre lungs show signs 
f the early canalicular phase visible as beginning dilation of the alveolar lumen in some areas but the 
alveolar septae remain thick and formation of the gas exchange unit is missing. 
d
o
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Figure 13: Morphogenetic phenotype of GRCol1-Cre animals 
Morphometric measurements of E18.5 GRCol1-Cre and GRnull embryos as well as their respective 
littermate controls were performed on semi-thin sections. Both mutations lead to a similar strong and
significant increase of the mesenchymal compartment at the expense of the alveolar compartment 
while the epithelium appears unaffected. 
pseudoglandular stage at E18.5 (Figure 12). At this stage, alveolar space was 
virtually absent in GRCol1-Cre lungs and the mostly unexpanded rosettes were 
surrounded by thick mesenchyme. Figure 13 displays morphometric results of 
GRCol1-Cre and control lungs describing these findings in a quantitative manner. The 
alveolar compartment is strongly decreased to less than 10% of the total area 
whereas the mesenchyme expands to over 60%. In addition, these measurements 
were also performed on lungs from GRnull embryos and their littermates revealing the 
close quantitative similarity of the phenotypes observed in the conditional and the 
germ line mutation, respectively. 
Periodic acid-Schiff (PAS) staining for the detection of glycogen as well as 
immunohistochemistry for T1α and proSPC demonstrated that the proximo-distal 
patterning of the respiratory tube was not affected in GRCol1-Cre animals (Figure 14). 
At E16.5, distal glycogen-rich epithelium could be clearly distinguished from proximal 
glycogen-free airways in mutant as well as control lungs. Moreover, both genotypes 
expressed the maturation-independent epithelial marker T1α at E18.5. However,  
Figure 14 (next page): Proximo-distal patterning is unaffected in GRCol1-Cre animals 
A) Violet periodic acid Schiff (PAS) staining visualizes the high glycogen content of the immature distal 
lung epithelium. At E16.5, both, controls and mutants show a clear separation of the distal glycogen-
the staining becomes discontinuous in the 
r airways. Although mutants preserve the 
rich epithelium from the more proximal parts. Until birth, 
alveolar sacs of controls while it appears in the large
glycogen pattern of the pseudoglandular phase until E17.5, they afterwards show a progressive loss of 
epithelial glycogen indicating an epithelial maturation which is advanced with respect to the 
morphological appearance. B) Immunohistochemistry for the epithelial differentiation marker T1α 
yields continuous staining of the epithelial cell layer in mutants as well as controls. C) 
Immunohistochemistry for the surfactant protein proSPC illustrates the retardation in epithelial 
differentiation. The transition from the continuous staining, which is still obser
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ved in the mutants at 
E17.5, to the punctual staining of the mature lung occurs with a delay of ~1-2 days. 
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Figure 15: Ultrastructural phenotype of GRCol1-Cre and GRnull embryos 
Electron microscopy shows that mutant epithelia are composed of immature, cuboidal type II cells
which preserve the ability to synthesize and secrete pulmonary surfactant as indicated by the
presence of multiple lamellar bodies within the cells as well as the alveolar lumen (arrows). Vessels
(V) get close to the alveolar lumen in control but not in mutant lungs. * indicates exemplary areas with 
disorganized ECM and loose cell contacts which is in contrast to the fusion of the cell layers in control
lungs. 
distal epithelial differentiation was significantly delayed as indicated by the proSPC 
expression pattern and the preserved high glycogen content in epithelial cells until 
birth (Figure 14). 
Electron microscopy was applied to monitor ultrastructural changes associated with 
the mesenchyme-specific inactivation of the GR gene. Type I cells are completely 
missing and type II cells display the typical cuboidal morphology of epithelial 
precursor cells. However, the ATII cells possess the ability to synthesize and secrete 
surfactant-containing vesicles. Between the unexpanded rosettes of the epithelium, 
the mesenchymal cells appear disorganized, form only loose contact and are 
surrounded by extensive deposition of extracellular matrix (ECM). Virtually 
indistinguishable observations were made in lungs of GRnull embryos showing that 
GRCol1-Cre animals recapitulate the lung phenotype observed in the germline mutation 
(Figure 15). 
Furthermore, close ultrastructural inspection of GRCol1-Cre as well as GRnull lungs 
identified more apoptotic cells in both mutants compared to their control littermates 
(Figure 16). To corroborate those findings, TUNEL staining (data not shown) and 
immunohistochemistry for cleaved caspase 3 (Figure 16) were performed on paraffin 
sections. In line with other investigators, apoptosis was found to be in general a very 
rare event during murine lung development (Bellusci et al., 1996; Lindahl et al., 
1997). Hence, although apoptotic cells were found more frequently in the lungs of 
RCol1-Cre mice, this affects still a very small proportion of less then 1% of all cells.  G
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Figure 16: Increased apoptosis in lungs of GRCol1-Cre embryos compared to controls 
Electron microscopy identified apoptotic cells in lungs from GRCol1-Cre as well as GRnull embryos 
number of cells positive focollected at E18.5. IHC on 6µm paraffin sections also identified a higher r
cleaved caspase 3 in GR  compared to littermate control lungs. Arrows indicate apoptotic cells. Col1-Cre
To analyze whether a prolonged pregnancy would allow GRCol1-Cre animals to 
overcome the observed developmental block during lung development, pregnant 
mothers were injected with progesterone. Figure 17 shows HE stainings of GRCol1-Cre 
 dilation which is characteristic for the canalicular phase and thus 
Col1-Cre
and control lungs of a litter collected at E20 (one day beyond calculated delivery). 
While the controls show signs of beginning alveogenesis, mutant lungs are in the 
process of tubular
advanced compared to GR  mice delivered at P0. However, observation of 
Figure 17: Prolonged pregnancy advances lung morphology in GRCol1-Cre embryos 
Pregnancies were artificially prolonged by progesterone treatment. Control lungs at E20 display
secondary septae (arrows) and thus progressed to the alveolar phase of murine lung developme
Mutant lungs show widespread dilation of the alveolar saccules at E20 and appear advanc
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compared to mutants born at natural P0.
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litters after delivery by caesarean section revealed that in contrast to their littermates, 
mutants of similar and even older age were still not able to survive and died within 20 
to 30 minutes after birth. Hence, an artificially prolonged pregnancy indeed improves 
lung morphology and enables GRCol1-Cre mice to progress through the early 
canalicular phase of murine lung development. Nevertheless, this is not sufficient to 
sustain postnatal survival and within the temporal limits of fetal development this 
describes differences in gene expression reflecting the morphological phenotype 
observed in GRCol1-Cre mice (Figure 18A).  
Quality and integrity of the RNA were verified by RNA LabChips prior to the labelling, 
hybridization and scanning procedure. Chip quality was confirmed in dChip (data not 
shown) and expression values were calculated based on the GC-RMA method.  
At E16.5, a comparatively small set of 40 genes was differentially regulated in mutant 
strong delay effectively leads to an arrest at the transition from the pseudoglandular 
To monitor transcriptional differences caused by mesenchymal GR inactivation, gene 
expression profiling was performed using Affymetrix microarrays. Whole lysates from 
the left lobe of mutant and control lungs, respectively, were used for RNA extraction 
and two time points were chosen: E16.5 when mutant and control lungs are 
morphologically indistinguishable but the differential transcriptional basis for the 
subsequent developmental changes is expected to be established. In contrast, E18.5 
compared to control lungs (>1.5-fold, p<0.005) (Figure 18A and Table 4 in the 
appendix). As expected, GR (Nr3c1) was among the 23 down-regulated genes, 
demonstrating the conditional inactivation at this time point.  
The Gene Ontology (GO) database (www.geneontology.com
to the canalicular phase. 
 
4.6. Gene expression profiling on lungs from GRCol1-Cre embryos 
) provides hierarchical 
clustering of biological terms within its three organizing principles: biological 
processes, cellular components and molecular functions. Above that, it connects 
gene products with these ontologies which allows the identification of specific terms 
associated with a particular set of genes. GO analysis of probe sets differentially 
expressed at E16.5 identified genes connected to “lung and respiratory tube 
formation” to be significantly over-represented, consistent with the idea that targeting 
ove e gene set GR will affect central processes of lung development. More r, the sam
was also over-represented in GO terms related to “collagen and extracellular matrix”. 
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Figure 18: Gene expression profiling 
A) RNA was extracted from GRCol1-Cre and control lungs at E16.5 and E18.5. Numbers of differentially
regulated genes at both time points are indicated. B) The proportional contribution of epithelial and
mesenchymal cells is comparable between the genotypes at both time points. Expression analysis of
mesenchymal marker vimentin did not reveal considerable differences between mutants and controls 
at any time point. 
A large number of 618 genes was found to be differentially expressed in mutants 
compared to control animals at E18.5. Among these, 267 were up-regulated while 
351 showed a decreased expression in GRCol1-Cre lungs (Figure 18A). 
Interpretation of the obtained expression values is complicated by the fact that RNA 
was extracted from whole lung lysates containing the whole variety of cell types of 
the developing lung. Thus, observed differences do not necessarily represent 
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changes at the transcriptional level but may also reflect altered proportions of cell 
populations. Vimentin is frequently used as a marker for mesenchymal cells as well 
as for normalization to mesenchymal proportions of mixed cell pools from 
mesenchymal and epithelial origin (Shirakihara et al., 2007). Therefore, its 
expression values were extracted from the gene expression profiling, revealing that 
the abundance of vimentin mRNA did not differ significantly between the genotypes 
neither at E16.5 nor at E18.5 (Figure 18B). This indicates that the proportional 
contribution of epithelial and mesenchymal cells to the observed expression values in 
whole lung lysates is comparable in GRCol1-Cre and control mice, respectively. 
 
4.7. Identification of changes in gene expression associated with 
developmental progress 
Apart from a direct comparison at a particular stage, the chosen time points allow in 
addition the description of changes in gene expression which are associated with the 
developmental progression from E16.5 to E18.5 in control and GRCol1-Cre mice, 
respectively. For this analysis, the criteria for significance were set at a fold change 
Figure 19: Changes in gene expression associate  the differential developd with ment in GRCol-Cre
and control lungs 
A) Illustration of the analytical approach used to monitor genes differentially expressed throughout
development from E16.5 to E18.5 in mutant and control lungs. Blue arrows indicate the comparison of 
expression profiles used for the calculation of the Venn diagram in B). 
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>2 combined with a p-value <0.001 and the probe sets following these criteria are 
illustrated in a Venn diagram (Figure 19B). The numbers within the circles represent 
those genes showing a significant change in expression from E16.5 to E18.5 in lungs 
of controls (Dev Ctr) and/or in GRCol1-Cre mice (Dev Mut). In addition, it is taken into 
consideration whether there is a significant quantitative difference between the 
changes observed in the two genotypes and the number of those genes is found in 
the circle Dev Diff (Figure 19A). 
To identify GR-regulated genes explaining the observed phenotypical changes in 
GRCol1-Cre mice, probe sets of the indicated area 4 in the Venn diagram were selected 
hich therefore A) were differentially regulated in controls from E16.5 to E18.5,  
 same period 
gnificant change in the differential expression. This 
analyzed in more detail. 
w
B) did not respond with a significant change in mutant lungs during the
and C) showed in addition a si
gene set was subsequently subjected to GO analysis to detect ontological pattern, 
which might help to define critical mediators of glucocorticoid action (Table 1). This 
GO analysis revealed that the vast majority of these genes could be classified in two 
main topics, “proliferation” and “extracellular matrix”. Therefore, these aspects were 
Table 1: Gene ontology analysis of particular gene sets 
The probe sets extracted from the area 4, indicated blue in Figure 19, were subjected to GO analysis
and exemplary clusters are described in the upper part of the table. These can be compared to results
obtained by GO analysis of the genes differentially regulated between mutants and controls at E16.5
as indicated by the red arrow in Figure 19. 
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4.8. Increased proliferation in the lungs of GRCol1-Cre mice 
At the single gene level, area 4 included a number of known effectors of cell cycle 
regulation (Table 2). While genes important for the progression through the cell cycle 
such as cyclins A2 and B2 or Cdc2A (cell division cycle 2 homolog A) and Cdc20 
as epithelium-specific mutants (GRCol1-Cre and GRSpc-Cre, 
spectively) were analyzed at embryonic day E18.5 and compared to their littermate 
f proliferating cells per 
total cell number and was found to be significantly increased in lungs of GRCol1-Cre 
mice compared to control lungs. In contrast, GRSpc-Cre mice displayed a pulmonary 
proliferation rate comparable to their control littermates (Figure 20A). 
To distinguish in GRCol1-Cre mutants proliferating cells in the epithelium and the 
were less down-regulated, the induction of well described differentiation markers is 
absent in GRCol1-Cre animals. In particular, the expression of the cyclin-dependent 
kinase inhibitor p21cip was strongly increased in control animals from E16.5 to E18.5 
and remained virtually unchanged in mutants. 
In order to detect changes in the proliferation rate of fetal lungs, mothers were 
injected with Bromodeoxyuridine (BrdU) two hours prior to embryo collection. BrdU is 
a synthetic analogue of thymidine and is incorporated into the DNA of replicating 
cells during the S-phase of the cell cycle. Specific antibodies then allow the 
immunohistochemical detection of these cells on tissue sections.  
Mesenchyme- as well 
re
controls. The proliferation index is defined as the percentage o
Table 2: Exemplary genes from the proliferation cluster identified by GO analysis 
 Figure 19, i.e. they showed a significantThese genes were represented in area 4, indicated blue, in
change in controls from E16.5 to E18.5 but not in mutants and these developmental changes were in
addition significantly different among the genotypes (criteria for significance were a fold change >2 and
p<0.001). Furthermore, GO analysis identified them to be associated with proliferation and control of
cell cycle regulation. 
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Figure 20: Increased proliferation in GRCol1-Cre embryonic lungs 
A) 6µm paraffin sections of E18.5 lungs from mutant and controls treated with B
embryo collection were stained with an anti-BrdU antibody and counterstained
rdU two hours prior to 
 with hematoxylin. The 
muta s the
proliferation index is defined as the percentage of BrdU positive cells relative to all nuclei. It was 
calculated as overall proliferation index for E18.5 GRSpc-Cre and GRCol1-Cre nts as well a ir 
respective control littermates showing a significant increase of GRCol1-Cre but not in GRSpc-Cre litters.  
B) Double labelling of BrdU and the epithelial marker T1α allows the calculation of separate values for 
the epithelium and the mesenchyme. This did not reveal a significant difference in the increased 
proliferation rate in the two compartments compared to the total proliferation index. 
mesenchyme, double-labelling with antibodies against BrdU and the epithelial marker 
T1α was performed. However, calculation of separate values for the two 
In summary, mesenchyme-specific inactivation of the GR gene leads to a significant 
increase in the general proliferation rate which is in accordance with the results of the 
expression profiling. 
 
4.9. Changes in ECM composition in the lungs of GRCol1-Cre mice 
In addition to genes associated with the regulation of proliferation, the expression 
profiling also identified numerous components of the extracellular matrix (ECM) as 
well as ECM-modifying enzymes to be differentially expressed (Table 3). This 
included representatives of all major constituents of the lung ECM, i.e. collagens, 
racting with 
important elastin-crosslinking enzyme lysyl-oxidase was significantly down-regulated 
compartments revealed that the proliferation index increased in the epithelium as well 
as in the mesenchyme to a similar extent and both did not reveal a significant 
difference to the rise in the total proliferation index (Figure 20B).  
elastic fibres and proteoglycans, but also cell surface molecules inte
those. 
For instance, elastin expression in GRCol1-Cre embryos did not follow the strong 
increase observed in their control littermates from E16.5 to E18.5 and the most 
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Table 3: Exemplary genes from the extracellular matrix cluster identified by GO analysis 
xtracellular matrix. 
These genes were represented in area 4, indicated blue in Figure 19, i.e. they showed a significant
change in controls from E16.5 to E18.5 but not in mutants and these developmental changes were in
addition significantly different among the genotypes (criteria for significance were a fold change >2 and
p<0.001). Furthermore, GO analysis identified them to be associated with the e
at both time points (Figure 21A). Elastogenesis also involves the balanced synthesis 
of microfibril proteins such as fibrillins and fibulins, which act as a scaffold for elastin 
assembly and are essential for this process (El-Hallous et al., 2007; Hubmacher et 
l., 2006; Kostka et al., 2001). In line with the emergence of all these probe sets, 
 could not be 
lungs, these changes did not reach significance (data not shown). In contrast, 
 for m
a
Goldner-Elastika staining revealed that the formation of elastic fibres
detected in the distal lungs of GRCol1-Cre animals while elastogenesis around larger 
bronchi and vessels was not affected (Figure 21B). 
Laminins are a central part of basal membranes and known to show a dynamic 
expression pattern throughout lung development (Nguyen and Senior, 2006). 
Although the developmental switch for instance from laminin α1 to α5 was delayed in 
mutant 
significant differences could be observed embers of the integrin family which 
form the cellular laminin receptors as well as laminin interaction partners such as 
fibronectin and certain collagens (Table 3) (Kreidberg et al., 1996).  
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Figure 21: Changes in components of the ECM 
A) Elastin and its major cross-linking enzyme lysyl-oxidase show different expression values in mutant 
compared to control lungs. * indicates a fold change >1.5 and p<0.005; *** indicates a fold change >2 
and p<0.001, *** in the title indicates a significant difference in the developmental profile B) Goldner-
Elastika staining of E18.5 lungs demonstrates violet elastic fibers (arrows) in the alveolar area in
controls. In mutant lungs, elastin deposition is only detected around larger airways (not shown) and
vessels (indicated by arrowheads) C) Immunohistochemistry for collagen I/III shows widespread
collagen deposition in mutant lungs. In controls, maturation coincides with loss of immunoreactivity. 
Insets show a lower magnification overview. 
Immunohistochemically, these changes in the overall composition of the ECM 
were exemplified using an antibody against the collagens I/III, demonstrating 
persistent and strong staining of collagen fibres in GRCol1-Cre animals. In control 
animals instead, pulmonary maturation coincided with reduced immunoreactivity 
for these collagens and prominent staining was only observed in the most distal 
parts, in particular near bronchi and bronchioles (Figure 21C). 
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4.10. Mesenchyme-specific loss of GR influences known signalling pathways of 
pulmonary morphogenesis 
For a number of signalling molecules, a critical role during proper lung development 
is well documented, such as transforming growth factor β (TGFβ), fibroblast growth 
factors (FGFs) or sonic hedgehog (Shh). In their target cells, these molecules exert 
actions which affect the activity of diverse transcription factors and ultimately give 
rise to the differential expression of target genes (Shannon and Hyatt, 2004). 
Therefore, expression values from the microarray experiment were used to monitor 
the effect of mesenchyme-specific GR ablation on the activity of accepted regulators 
of lung development and some of these are shown in Figure 22. 
TGFβ signalling and in particular its influence on the regulation of the ECM are well 
known effectors during lung development (Shi et al., 1999; Zeng et al., 2001). While 
the increase in TGFβ1 expression during late development in controls is only mildly 
attenuated in GRCol1-Cre mice, TGFβ2 and 3 show a contrary behaviour in mutants 
compared to controls. Their strong decrease from E16.5 to E18.5 in controls is 
contrasted by a significant up-regulation in mutant lungs. In accordance, a variety of 
constituents of the ECM were found to be differentially regulated as well and have 
been described above.  
Members of the FGF family and their receptors have been described to mediate 
respiratory tube growth and branching but also functional maturation prior to birth. In 
particular, FGF9 expressed in the mesothelium and the epithelium has been shown 
increased expression of proliferation markers (see section 4.8.) in parallel with a 
to act together with Shh signalling to promote mesenchymal proliferation and growth 
factor synthesis (White et al., 2006). Apart from gene products associated with 
proliferating cells, FGF7 is up-regulated which in turn promotes epithelial maturation 
and alveolar dilation (Shi et al., 1999; Tichelaar et al., 2000; Zeng et al., 2001). In 
GRCol1-Cre mice, FGF9 as well as a particular set of Shh target genes do not follow the 
developmental pattern observed in the control lungs and this translates into an 
lower expression of FGF7. The Shh target genes Gli1 and Gli2 are significantly 
down-regulated in controls at E18.5 compared to E16.5 while the decrease over the 
same period in GRCol1-Cre lungs does not reach significance. In the case of Gli1, this 
significantly different developmental change leads to a similarly significant difference 
 41
  Results 
in expression at E18.5 between the genotypes. In contrast, another Shh target gene, 
Ptc1, does not display significant differences among any of the two conditions. 
 
4.11. Analysis of vascular differentiation in GRCol1-Cre mice and endothelium-
specific inactivation of the GR gene 
The capillary system surrounding the alveoli has been shown to arise from the 
primitive lung mesenchyme through vasculogenesis, a process involving various 
interactions between the differentiating endothelial and epithelial compartments 
(Stenmark and Abman, 2005). Importantly, interference with the precise control of 
these signalling events causes malformations of the respiratory system, leading to 
Figure 22: Expression values of genes known to be involved in the regulation of lung
morphogenesis 
Expression values were extracted from the gene expression profiling. * indicates a fold change >1.5
and p<0.005; *** indicates a fold change >2 and p<0.001, */*** in the title indicates a significant
difference in the developmental profile (Dev Diff). Significant differences between genotypes are
indicated with bars while */*** at E18.5 indicates a significant change compared to E16.5. 
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Figure 23: Endothelial differentiation in GRCol1-Cre animals 
A) Expression values of selected genes involved in endothelial differentiation. * indicates a fold change 
>1.5 and p<0.005; *** indicates fold change >2 and p<0.001, */*** in the title indicates a significant 
difference in the developmental profile (Dev Diff). Significant differences between genotypes are 
indicated with bars while */*** at E18.5 indicates a significant change compared to E16.5.  
B) Immunohistochemistry for the endothelial marker Pecam1 shows continuous staining around the 
alveoli in mutants and controls at E17.5. At E18.5, the staining in control lungs becomes more 
condense while GRCol1-Cre animals maintain the staining pattern observed in the E17.5 lung (indicated 
by arrows). 
inadequate lung function and even death (Del Moral et al., 2006b; Yamamoto et 
al., 2007; Zeng et al., 1998).  
The expression profiling identified a number of differentially regulated genes which 
are known to participate in the regulation of endothelial development such as 
Col1-Cre mice, lung sections were stained with an antibody against 
tors 
 
vascular endothelial growth factor (VEGF), VEGF receptor (VEGF-R) and endothelial 
differentiation gene 2 (Edg2) (Figure 23A). To investigate the extent of vascular 
differentiation in GR
Pecam1 (CD31) which labels specifically endothelial cells and their progeni
(Figure 23B). A continuous staining surrounding the complete alveolus can be
observed at E17.5 in control as well as mutant embryos. In controls, this staining 
becomes condensed and intensifies throughout the subsequent maturation as the 
alveolar lumen dilates and the thickness of the septae is reduced. In contrast, 
GRCol1-Cre lungs preserve the immunohistochemical appearance of the 
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Figure 24: Endothelium-specific inactivation of the GR gene 
Immunohistochemistry against GR on 6µm paraffin sections shows GR protein in endothelial cells (red 
arrow) and pericytes (black arrow) in control animals. In mutants, GR is still detected in pericytes 
(black arrow) while endothelial cells do not show immunoreactivity (red arrow). Insets show HE 
staining of 4.5µm paraffin sections. No significant differences in lung morphology were noted between 
the two genotypes. 
pseudoglandular vasculature, corresponding to the general phenotype of these 
mutants (Figure 23B). 
 of GR in cells of the vascular system during In order to investigate a potential role
murine lung development, animals lacking GR specifically in the endothelium were 
generated. Mice expressing the Cre recombinase under regulatory 
promotor/enhancer elements of the Tie2 gene (Constien et al., 2001) were crossed 
with GRflox animals (Tronche et al., 1999). The resulting GRflox/flox/Tie2-Cre (GRTie2-Cre) 
mutants did neither show respiratory distress nor other obvious dysfunctions after 
birth. Consequently, E18.5 embryos were analyzed for pulmonary maturation but no 
significant differences were noted upon morphological examination of HE stained 
paraffin sections (Figure 24, insets).  
The efficacy of the endothelial recombination was confirmed by 
immunohistochemistry. GR staining is detectable in endothelial cells as well as 
pericytes in control animals whereas in GRCol1-Cre lungs only the pericytes preserve 
positive immunoreactivity (Figure 24).  
 
4.12. Generation of an inducible, endothelium-specific Cre line Tie2-CreERT2 
The constitutive Tie2-Cre line applied before is known to recombine unspecifically in 
cells of the hematopoietic system during development (Constien et al., 2001). To 
further improve the analysis of gene function in endothelial cells specifically at the 
adult stage, a Cre line was established expressing the CreERT2 fusion protein under 
control of the regulatory elements of the mouse Tie2 gene. To generate these mice, 
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Figure 25: Tie2-CreERT2-mediated recombination in endothelial cells of various organs 
Whole mount β-galactosidase staining of organs collected from mice positive for the Rosa26 Cre
reporter and carrying the Tie2-CreERT2 transgene. Only after treatment with tamoxifen, widespread 
blue staining is observed in a pattern consistent with the vasculature sys  tem.
a BAC was selected which contained ~80kb upstream and ~60kb downstream of 
the Tie 2 gene and the processing was essentially performed as described in 4.1., 
except that the targeting construct contained the sequence of the CreERT2. This 
on tamoxifen application the fusion protein 
anslocates into the nucleus where it mediates recombination (Feil et al., 1997; 
fusion protein consists of the Cre recombinase and a mutated ligand binding 
domain (LBD) of the estrogen receptor (ER) which binds specifically the synthetic 
ligand tamoxifen but not endogenous estrogens. The ER-LBD retains the Cre 
molecule in the cytoplasm and only up
tr
Kellendonk et al., 1999; Kellendonk et al., 1996; Weber et al., 2001). 
Purification, oocyte injection and analysis of the resulting mice were performed as 
described before (section 4.1.). Fourteen animals carrying the transgene were 
identified as potential founders and crossed to Rosa26 Cre reporter mice for the 
validation of Cre activity. Eight founders successfully transmitted the transgene and 
resulting R26R/Tie2-CreERT2 (Rosa26Tie2-CreERT2) offspring of six founders was 
subjected to an established induction protocol (Erdmann et al., 2007). At the age of 
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Figure 26: The Tie2-CreERT2 transgene mediates recombination in endothelial cells of various
vessel types but not in the bone marrow 
bination 
ze,
β-galactosidase staining is discontinuous in the aorta and the vena cava but complete recom
is observed in the capillary system exemplified by the mesenteric tissue. With increasing vessel si
the staining becomes progressively discontinuous and is mosaique in the aorta and the vena cava. No
recombination was detected in cells of the hematopoietic system (bone marrow). 
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eight weeks, the mice received two injections of 1mg tamoxifen or vehicle for five 
s 
o f 
l 
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se activity was 
tai es disco
consecutive days and were sacrificed another ten days thereafter. Three line
displayed the expected recombination pattern and LacZ data are shown f r one o
them (Figures 25 and 26). Recombination was specifically detected in endothelia
cells in various organs whereas β-galactosidase staining was neither observed i
cells of the hematopoietic system (bone marrow), nor in other non-endothelial ce
types. Importantly, Cre activity was also not revealed in vehicle-injected animals.  
The extent of Cre-mediated recombination was strongly dependent on the size and
type of the vessels. Upon tamoxifen treatment, strong β-galactosida
observed in virtually all cells of the capillary system, for instance in the lung, kidney 
or most clearly visualized in mesenteric tissue. Instead, the β-galactosidase staining 
became mosaique with increasing size of the vessels and this effect was more 
pronounced in the arterious compared to the venous compartment. Reflecting this 
pattern, β-galactosidase s ning becom ntinuous in the vena cava and the 
aortic endothelium shows only scattered recombination (Figure 26). 
  Discussion 
 
 
5. Discussion 
 
The beneficial effects of glucocorticoids for the acceleration of fetal lung maturation 
are well known after the initial experiments performed by Liggins and colleagues on 
sheep in 1969 (Liggins, 1969). Since then, corresponding actions have been 
described for a broad range of mammalian species, ranging from rodents over cattle 
to, and most importantly, humans (Liggins and Howie, 1972; Snyder et al., 1981; 
Zaremba et al., 1997). Clinical studies have further confirmed the advantageous 
outcome of glucocorticoid application and have led to their recommendation as
standard regimen of care in preterm infants (Gilstrap et al., 1995). 
However, pharmacological doses of glucocorticoids are known to be associated with 
considerable side-effects. Experiments in rodents, (non-human) primates and 
 
rgans and an increased risk for cardiovascular 
action in the fetal lung are desirable and might provide alternative strategies to treat 
oid 
transrepress via 
interactions with other transcription factors whereas classical homodimeric binding to 
humans have revealed that glucocorticoid treatment leads to growth retardation, 
premature differentiation of several o
disease as well as mental disorders such as unipolar depression (Reinisch et al., 
1978; Seckl, 2004). Thus, further insights into the mechanisms of glucocorticoid 
preterm infants. 
Apart from pharmacological stimulation, the critical role of glucocorticoid signalling 
has also been demonstrated by gene ablation and consequent loss of glucocorticoid 
action in mice. GR knockout mice die immediately after birth due to respiratory failure 
and display strong pulmonary alterations including mesenchymal thickening and 
strongly reduced airspace (Cole et al., 1995). The essential role of glucocortic
signalling was corroborated by results from mice with genetic inactivation of the CRH 
gene (Muglia et al., 1999). Leading to a marked glucocorticoid deficiency and 
postnatal lethality, this mutation causes a lung morphology strongly reminiscent of 
the GR knockout phenotype.  
GR actions can be mediated by direct binding to GREs as a homodimer or by 
interaction with other transcription factors. Dimerization-defective mice were 
generated to allow the distinction of different modes of GR action (Reichardt et al., 
1998). In these animals, GR retains its ability to transactivate and 
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GREs is perturbed. Interestingly, these mice are viable indicating that the essential 
nctions of GR in the developing lung are mediated via protein-protein interactions.  
.1. Conditional inactivation of the GR gene in different cellular compartments 
ralocorticoids and 
k involving various cell types of epithelial and mesenchymal origin. 
ree transgenic founder animals was obtained 
such as the nuclear receptor co-repressor hairless, the 47kd polypeptide of the DNA-
fu
 
5
of the developing lung 
Targeted gene inactivation in mice is a powerful tool for the analysis of gene function 
and has been proven valuable in the investigation of glucocorticoid signalling. It 
provides strong specificity and reliable ablation of gene function while 
pharmacological blockade or adrenalectomy with subsequent glucocorticoid 
replacement bear considerable disadvantages. Receptor antagonists show a certain 
degree of un-specificity and do not guarantee complete blockade while 
adrenalectomy removes apart from glucocorticoids also mine
catecholamines. Finally, investigation of embryonic development further complicates 
the pharmacologic intervention while surgical manipulation is virtually precluded. 
The Cre/loxP recombination system has enabled the investigation of gene function in 
cases where complete gene inactivation leads to early lethality. Moreover, it also 
allows a cell type-specific analysis to distinguish contributions of certain cell 
populations to a given paradigm.  
In the developing lung, morphogenesis and maturation depend on a delicate 
signalling networ
Therefore, a series of Cre-transgenic lines was applied to investigate the role of 
these respective cell types for the glucocorticoid-mediated maturation of the murine 
lung and two of these lines were generated in the course of the present studies.  
 
5.1.1.  mSftpc-Cre 
Efforts to generate a BAC-derived transgene expressing the Cre recombinase 
specifically in the lung epithelium under the regulatory elements of the Sftpc gene 
locus failed. Only a small number of th
and none of these was able to transmit the transgene to the F1 generation. While 
BACs imply the advantage of reliable copy number-dependent and integration site-
independent expression, they also bear the risk of co-expression of potentially 
unfavourable genes present on the BAC. In the case of the applied BAC RP24-
252D18, a number of other genes are found in close proximity to the Sftpc locus, 
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directed RNA polymerase III or Bmp1 encoding bone morphogenic protein (BMP1) 
and mammalian Tolloid (mTLD). Although detailed knowledge through over-
expression studies in the mouse is missing in most cases, some candidates might 
ellular metalloproteinase which orchestrates ECM 
 characterized and used to drive the expression of 
.1.3. Col1-Cre 
e line expresses the Cre recombinase from a 100kb P1 artificial 
explain or contribute to the failure to establish a BAC-based mSftpc-Cre line. For 
instance BMP1 is an extrac
assembly but also activates the TGFβ-like proteins BMP2 and BMP4. 
Overexpression studies demonstrated a crucial role of BMP1 in dorsal-ventral 
patterning (Hopkins et al., 2007), whereas mice with a targeted mutation in the Bmp1 
gene do not survive beyond birth (Suzuki et al., 1996). In conclusion, plasmid-based 
transgenes might prove superior in particular cases when suitable BACs are not 
available. 
 
5.1.2. Spc-Cre 
In the course of these studies, a plasmid-based epithelium-specific Cre transgenic 
mouse line was published (Okubo and Hogan, 2004; Okubo et al., 2005). It employs 
3.7kb of the promotor from the human gene encoding surfactant associated protein C 
(SPC), which has been extensively
various proteins in cells of the developing lung epithelium (Glasser et al., 1991; 
Korfhagen et al., 1990; Perl et al., 2002; Tichelaar et al., 2000; Wert et al., 1993). 
The specificity was confirmed using the Rosa26 Cre reporter line (Soriano, 1999) and 
faithful recombination was achieved in combination with the conditional GR allele. 
 
5
This transgenic mous
chromosome (PAC) containing the locus of the collagen type (I)-alpha 2 gene (Florin 
et al., 2004). During embryogenesis as well as in adult animals it mediates 
recombination in cells of mesenchymal origin such as dermal fibroblasts, 
mesenchymal cells of blood vessel walls and cells of the connective tissue. In the 
developing lung, the Col1-Cre transgene efficiently targets the whole mesenchymal 
compartment including the endothelium of the capillary system which surrounds the 
developing alveolus and is derived from the primitive lung mesenchyme through 
vasculogenesis.  
 
 49
  Discussion 
5.1.4. Tie2-Cre 
The applied plasmid-based transgenic line employs promotor/enhancer elements of 
the mouse Tie2 gene to direct Cre expression specifically to endothelial cells 
(Constien et al., 2001). This includes vessels originating from angiogenesis but also 
the endothelial progenitor cells which arise from the primitive mesenchyme during 
vasculogenesis of the lung capillary system and which have been characterized by 
the expression of TIE2 (White et al., 2006). 
 
5.1.5. Tie2-CreERT2  
In order to enable a versatile applicability of the Cre/loxP recombination system in 
ndothelial cells, a BAC-transgenic mouse line was generated which expresses a 
tamoxifen-inducible recombinase CreERT2 under the regulatory elements of the Tie2 
of Tie2-Cre lines has been published so far, however, all these 
nal 
thality precluding detailed analysis in later development and adulthood (George et 
p-Kistner et al., 1999; Shalaby et al., 1995). Employment of an 
inducible CreERT2 allows activation at any desired time point and therefore 
opoietic system in induced animals. 
e
gene. A variety 
transgenes relied on various combinations of promotor and/or enhancer fragments 
and resulted in very diverse and mostly incomplete recombination pattern (Forde et 
al., 2002; Kisanuki et al., 2001; Li et al., 2005b). The constitutive plasmid-based Tie2-
Cre applied in the present study provides faithful recombination in endothelial cells 
but activity has also been observed in cells of the hematopoietic system during 
embryonic development. Moreover, targeting of genes essential for the developing 
vascular system extends also to the yolk sack and the extraembryonic vasculature. 
Frequently, this renders the mutants particularly vulnerable to early midgestatio
le
al., 1993; Schorp
circumvents potential fatal outcomes as well as unwanted recombination in cells of 
the hematopoietic system during development. 
In line with previous attempts, the oocyte injections of the Tie2-CreERT2 construct 
yielded founders with mostly surprisingly high copy numbers of the BAC transgene 
(J. Elzer, personal communication; Table 5 in the appendix). Analysis of 
β-galactosidase activity in R26RTie2-CreERT2 animals identified three lines which 
showed the expected recombination pattern and one of these was investigated in 
more detail. Importantly, recombination was neither detectable in the absence of 
tamoxifen nor in cells of the hemat
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R26RTie2-CreERT2 animals demonstrated prominent β-galactosidase activity in the 
on of mice with inducible endothelium-
pecific protein loss. 
 
-specific inactivation of the GR gene retards lung 
 under control of a 3.7kb promotor of 
capillary system of a variety of organs including lung, kidney and the mesenteric 
tissue. With increasing vessel size, this staining became progressively mosaique and 
was only scattered in the aorta. Since similar recombination pattern were observed in 
all three lines, this most likely reflects the restricted activity of the Tie2 locus in sub-
populations of endothelial cells. Further investigation is warranted to analyze the 
suitability of this Cre line for the generati
s
5.2. Lung epithelium
maturation but does not impair survival 
Beneficial effects of corticosteroids for lung maturation have commonly been 
attributed to their ability to induce the functional maturation of lung epithelial cells. 
Glucocorticoids have been shown to induce the synthesis and secretion of pulmonary 
surfactant in epithelial ATII cells, reducing the surface tension within the alveolus and 
thus preventing collapse (Mendelson, 2000). Moreover, corticosteroid receptors are 
known to induce the transepithelial sodium and water transport via regulation of the 
epithelial sodium channel (ENaC) (Itani et al., 2002; Nakamura et al., 2002). Apart 
from their general function in homeostasis, this is of particular importance for the 
rapid clearance of lung liquid during the perinatal transition from a fluid-filled lung to 
air-breathing, and mice lacking functional ENaC die within ten hours after birth due to 
respiratory distress (Hummler et al., 1996). In adult humans, glucocorticoids are also 
applied for the induction of lung liquid removal for instance in the case of high altitude 
pulmonary edema (Keller et al., 1995). 
For the investigation of GR function in lung epithelial cells, we used the Cre/loxP 
recombination system to generate mice lacking the receptor specifically in these 
cells. Animals expressing the Cre recombinase
the human Sftpc gene (Spc-Cre) were crossed with mice carrying a conditional GR 
allele. The resulting GRSpc-Cre mutants were born in mendelian frequency and 
survived to adulthood without macroscopic disturbances. Even when the GR dosage 
in non-targeted cells was reduced by introduction of one GRnull allele, these 
GRnull/flox/Spc-Cre animals were still obtained with the expected frequency of about 
25%. The efficacy of the Spc-Cre line has been characterized before (Okubo and 
Hogan, 2004; Okubo et al., 2005) and immunohistochemistry confirmed the 
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successful ablation of GR protein specifically in all epithelial cells of the developing 
lung. As a consequence, these findings demonstrate that lung epithelial GR is not 
essential for survival. 
Nevertheless, further histological analysis revealed a delayed progression through 
lung development in GRSpc-Cre embryos. Intriguingly, these effects were more 
prominently associated with the mesenchyme emphasizing the importance of 
epithelial-mesenchymal interactions and the developmental interconnectivity of the 
two compartments. Electron microscopy and morphometry revealed an increased 
ickness of the mesenchymal layer within the alveolar walls leading to significantly 
n of the 
mation of a functional alveolar gas 
th
reduced airspace in mutant mice. In contrast, attenuation and differentiatio
epithelium were preserved and allowed the for
exchange unit. However, the observed developmental delay in GRSpc-Cre animals is 
only transient and can be compensated within the first days of life or during an 
artificially prolonged pregnancy. 
 
5.3. Mesenchymal GR promotes progression through the canalicular phase of 
murine lung development and is indispensible for postnatal survival 
The mild phenotype in the epithelial GRSpc-Cre mutants strongly indicated an important 
function of GR in the surrounding lung mesenchyme. Consequently, mice lacking GR 
specifically in mesenchymal cells (GRCol1-Cre) were generated to investigate this 
conclusion. Remarkably, no mutants were found at weaning and observation of 
delivering mothers revealed that mutant pups died within the first hour after birth. 
They displayed respiratory distress and cyanosis reminiscent of the GR knockout 
phenotype. 
This striking similarity of GRCol1-Cre lungs to the phenotype of GR knockout animals 
was further substantiated by histological examination of GRCol1-Cre and control lungs. 
As in the germ line mutation, branching morphogenesis and general lung 
development were not affected in GRCol1-Cre embryos until E16.5. Subsequently, 
however, mutant lungs failed to progress through the canalicular and saccular phase 
and still displayed the primitive morphology of the pseudoglandular phase at E18.5. 
Unexpanded alveolar tubes were surrounded by cuboidal epithelial cells resulting in 
the lack of both, alveolar airspace as well as a functional gas exchange unit. The 
mesenchymal compartment was significantly increased but showed a disorganized 
appearance and was characterized by extensive deposition of ECM. Nevertheless, 
 52
  Discussion 
proximo-distal patterning of the epithelium was preserved, and although delayed, 
epithelial differentiation occurred as judged by differentiation markers and the 
presence of lamellar bodies. 
 of signalling molecules with appropriate properties 
as been identified. In particular, FGF7 is expressed in lung mesenchymal cells and 
 
ctant 
 lung development in controls and mutant mice  
Electron microscopy as well as immunohistochemistry identified an increased 
number of apoptotic cells in GRCol1-Cre mutants. However, considering the extremely 
low incidence of apoptosis during murine lung development (<1%) observed in this 
and other studies, it is unlikely that the moderate increase in GRCol1-Cre lungs has 
major consequences on the functional maturation of the mutant fetal lung (Bellusci et 
al., 1996; Lindahl et al., 1997). 
Knowledge about GR functions in the lung mesenchyme has been limited. In lung 
epithelial cell lines, the maximal induction of surfactant synthesis by glucocorticoids 
was dependent on the co-culture of lung fibroblasts, leading to the suggestion of a 
so-called fibroblast pneumocyte factor (FPF) (Smith, 1979). Although the latter has 
never been identified, a number
h
has been shown to be induced by glucocorticoids in cultured pulmonary fibroblasts.
Conditioned medium of these cells exerted a stimulating effect on the surfa
synthesis in cultured lung epithelial cells and this could be partially blocked by an 
antibody against FGF7 (Chelly et al., 2001). Interestingly, FGF7 was found to be 
differentially regulated in GRCol1-Cre lungs compared to control littermates and this 
finding will be discussed below (see section 5.5.). 
 
5.4. Profiling gene expression during the canalicular and saccular phase of 
murine
In general, GR acts as a ligand-dependent transcription factor and can thus be 
expected to mediate its essential effects through regulated expression of target 
genes. Profiling of gene expression using microarrays therefore not only advances 
the understanding of the observed phenotype to the transcriptional level but may also 
allow the identification of regulatory pathways critical for the GR-mediated maturation 
of the fetal lung.  
The vast majority of studies on mice with lung phenotypes monitored gene 
expression exclusively at embryonic day E18.5, a time point when the morphological 
alterations are typically already fully established (Basseres et al., 2006; Okubo et al., 
2005; Wan et al., 2004). This complicates a conclusive interpretation of the obtained 
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data, since the observed differences are unlikely to reflect primary effects of the 
mutation but rather characterize the transcriptional profile associated with the 
pathophysiological end point. Moreover, deployment of whole lung lysates for RNA 
n of RNA extracts from specific cell types. While the 
nalicular and saccular phase of 
urine lung development in control embryos, as well as an assessment to which 
he 
hymal marker gene 
s is caused by a failure to undergo appropriate morphogenetic 
extraction does in most cases not allow an assignment of the detected expression 
values to a specific cellular compartment. Alternatively, observed differences may be 
caused by relative changes in cell populations which affect their respective 
contribution to the RNA pool.  
Therefore, physical separation of epithelial and mesenchymal cells would be 
desirable to allow the applicatio
clear separation of these two compartments until E16.5 may enable sampling by 
techniques such as laser assisted microdissection, their fusion and close interaction 
during terminal maturation precludes these approaches. In addition, microdissection 
as well as the alternative enzymatic treatment with consecutive cell sorting requires 
intensive and time-consuming manipulation of the lung samples, deteriorating RNA 
quality and giving rise to possible experimental artefacts.  
Considering these general caveats of gene expression profiling on the developing 
lung, the following design for sampling and analysis was chosen. Whole lysates from 
mutant and control lungs were analyzed at E16.5 and E18.5, respectively, and 
special importance was given to the developmental profile between these two time 
points. The latter allows monitoring of the transcriptional changes which are 
associated with the progression through the ca
m
extent these processes are affected by the mesenchyme-specific loss of GR in t
mutants. Importantly, analysis of expression levels for the mesenc
vimentin did not reveal significant differences between GRCol1-Cre and control lungs 
indicating that mesenchymal and epithelial cells contributed to the RNA pool in a 
similar proportion in both genotypes. Moreover, this finding contributes an interesting 
aspect to the expansion of the mesenchymal compartment observed in the 
morphometric analysis. Together, these results suggest that the described phenotype 
in GRCol1-Cre lung
maturation rather than mesenchymal hyperplasia alone. This is in accordance with 
the observation that the increase in proliferating cells was not restricted to the 
mesenchyme but affected the epithelium to a similar extent. 
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5.5. Mesenchymal GR interferes with known regulatory pathways of murine 
lung development to alter the proliferative state and the composition of 
the extracellular matrix 
The analytical approach described above identified two critical processes to be 
affected by the conditional inactivation of GR in the developing lung mesenchyme, 
and these were further investigated by histological methods: Gene ontology analysis 
 
ression levels of various 
ffectors of this signalling complex (del Moral et al., 2006a; White et al., 2006). 
revealed an over-representation of genes connected to proliferation and cell cycle 
control, including well-known marker genes and regulators of lung development such 
as Cyclins A2 and B2, Ki67 and Nmyc. The latter has been shown to fulfil critical 
functions during lung development and is continuously expressed in mutant lungs 
from E16.5 to E18.5 while it is down-regulated in controls during the same period. 
Lung epithelium-specific deletion of Nmyc leads to a virtual absence of the lung while 
over-expression resulted in a phenotype similar to GRCol1-Cre animals characterized 
by impaired differentiation and ongoing proliferation. It has to be noted however, that
Nmyc is exclusively expressed in the epithelium which precludes a direct effect of GR 
on its regulation (Okubo et al., 2005). P21cip is a cyclin-dependent kinase inhibitor 
and regarded as an important regulator promoting terminal differentiation and 
inhibiting proliferation (Besson et al., 2008). Accordingly, p21cip is significantly up-
regulated in controls from E16.5 to E18.5 and this induction is completely abolished 
in mutant lungs. Interestingly, p21cip has been shown to be regulated by 
glucocorticoids in lung fibroblasts and other cell types, involving interaction of GR 
with the C/EBP (CCAAT/enhancer binding protein) family of transcription factors 
(Cram et al., 1998; Yang et al., 2007). 
These findings of cell cycle dysregulation were corroborated by in vivo BrdU labeling 
of proliferating cells and consecutive histological analysis. Compared to controls, the 
proliferation index was significantly increased in GRCol1-Cre lungs. Yet, subsequent 
determination of separate values for mesenchymal and epithelial compartments did 
not reveal significant differences, indicating that mesenchymal loss of GR does not 
exclusively regulate proliferation in the mesenchyme but affects the general 
proliferation rate of the developing lung including the epithelium. One important group 
of growth factors involved in the pulmonary cell cycle control are Shh together with 
the FGF family, and mesenchymal loss of GR altered the exp
e
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Produced in the epithelium, Shh and FGF9 act on the mesenchyme to promote 
F7 
re 
on of Shh and FGF9 target genes and the expression 
r inactivation of signalling molecules but also 
proliferation and their decline in the canalicular phase co-incides with a rise in FG
expression. In GRCol1-Cre lungs, FGF9 expression was only mildly attenuated, the
was a considerable dysregulati
of FGF7 which is important for epithelial maturation and dilation was not induced 
(Cardoso et al., 1997; Tichelaar et al., 2000). 
In addition to the impairment in the proliferative control in GRCol1-Cre lungs, the gene 
expression profiling also revealed a massive dysregulation of ECM components as 
well as ECM-modifying enzymes such as chitinase 3 or lysyl-oxidase. The observed 
changes affected all major constituents of the lung ECM, collagens (e.g. procollagen 
type IX alpha 1), elastic fibers (elastin, fibrillin and lysyl-oxidase) and proteoglycans 
(chondroitin sulfate proteoglycan), but also numerous cell surface molecules which 
interact with the ECM, for instance integrins. 
This is likely to affect the morphogenetic development of the lungs in various ways: 
The ECM provides structural support, which is particularly critical for a largely hollow 
organ, and becomes additionally important during processes such as cell adhesion 
and migration (Francis et al., 2002; Nguyen and Senior, 2006; Sakai et al., 2003). 
Moreover, lung maturation involves aspects of remodelling such as the attenuation of 
the epithelium or the thinning of the alveolar septae, including the fusion of the bi-
layered capillary system with the two epithelial layers. These processes can be 
expected to depend on the exertion of mechanical stretch and contraction, which in 
turn requires an appropriate anchorage. In addition, ECM functions have more 
recently been extended to the modulation of growth factor signalling by multiple 
modes such as enzymatic activation o
their sequestration or release. Thereby, the composition of the ECM influences the 
availability and activity of these molecules and thus determines their range of action 
(ten Dijke and Arthur, 2007). 
Indeed, in vivo models revealed important functions during lung development for 
many of the ECM genes identified by the gene expression profiling. For example, the 
induced expression of elastin as well as its major crosslinking enzyme lysyl-oxidase 
was significantly attenuated in GRCol1-Cre animals and knockout studies demonstrated 
an essential role during the alveolar maturation for both genes (Maki et al., 2005; 
Wendel et al., 2000). Fibronectin is another major component of the ECM which is 
strongly induced in control animals during the late phase of lung development, and 
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this induction is almost completely absent in GRCol1-Cre embryos. While the 
inactivation of the fibronectin gene results in early lethality before E10.5 (George et 
al., 1993), fibronectin deposition and its interaction with its cellular receptors, the 
integrins, has been shown to mediate critical functions during lung morphogenesis 
(Araya et al., 2006; De Langhe et al., 2005; Kreidberg et al., 1996). 
TGFβ-signalling plays a critical role in the orchestration of ECM composition and its 
endent transcriptional repression of the 
h as VEGF or PDGF signalling interferes with normal 
resulting properties (Derynck and Akhurst, 2007; ten Dijke and Arthur, 2007). In the 
present study, mesenchyme-specific loss of GR was associated with the differential 
expression of various genes and processes regulated by TGFβ, and expression 
values for different types of TGFβ proteins were changed as well. This ventures 
speculations that GR might interact in particular with TGFβ signalling to promote 
maturation of the respiratory system. Indeed, GR has been shown to interact with the 
TGFβ effector SMAD3 leading to ligand-dep
type-1 plasminogen activator inhibitor (PAI-1) gene (Song et al., 1999).  
 
5.6. Fibroblast but not endothelial GR mediates the essential effects of 
glucocorticoids on lung maturation 
Ablation of GR protein using the Col1-Cre transgene identified the lung mesenchyme 
as the critical site for glucocorticoid action during maturation of the respiratory 
system. However, the mesenchyme gives rise to a variety of cell types, including 
endothelial cells, smooth muscle cells as well as lipofibroblast and alveolar 
myofibroblasts. Therefore, investigating the effects on particular subpopulations may 
help to reveal potentially involved mechanisms. 
The capillary system surrounding the alveoli arises through vasculogenesis from the 
mesenchymal compartment and is one of its major derivatives (Stenmark and Gebb, 
2003). Moreover, mouse models have shown that disruption of signalling complexes 
important for this process suc
lung development (Del Moral et al., 2006b; Lindahl et al., 1997; Yamamoto et al., 
2007; Zeng et al., 1998). In addition, GR has been proposed to mediate 
glucocorticoid effects through transcriptional regulation of the VEGF receptor (Clerch 
et al., 2004). Since several of these factors known to determine endothelial 
development were differentially regulated in the expression profiling, a potentially 
critical function of GR in the lung through participation in the regulation of vascular 
differentiation was investigated. 
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However, immunohistochemistry for the endothelial marker Pecam1 did not reveal 
significant differences in staining pattern beyond those attributable to the 
morphological differences. In addition, mice lacking GR specifically in endothelial 
cells were generated, and these animals survived and did not show alterations in 
lung morphology at E18.5. These results exclude that GR fulfils an essential function 
yofibroblasts and lipofibroblasts are predominantly characterized by their ability to 
owever, 
in vitro, and instead, overlapping 
development in cells of the fibroblast 
analicular and saccular stage. The developmental 
through actions in endothelial cells. 
Apart from that, the primitive lung mesenchyme gives rise to smooth muscle cells 
(SMC) and cells of the fibroblast lineage, namely alveolar myofibroblasts and 
lipofibroblasts. SMCs enclose the shaft of the developing respiratory tube during 
branching morphogenesis and surround the complete bronchial airways in the 
mature lung (Kim and Vu, 2006). Branching morphogenesis is not altered in 
GRCol1-Cre animals and the mutation affects primarily the differentiation and dilation of 
the most distal alveolar saccules. Therefore, SMCs are unlikely to participate 
significantly in the glucocorticoid-mediated maturation of the fetal lung. 
M
provide contractile forces and lipid supply to the alveolar unit, respectively. H
their distinct actions have been studied mostly 
functional and biochemical characteristics have been described in vivo (Kim and Vu, 
2006; McGowan and Torday, 1997). Indeed, both cell types express smooth muscle 
actin and are involved in the deposition of ECM as well as the active participation in 
epithelial-mesenchymal signalling, which is in agreement with the observed effects in 
GRCol1-Cre animals. Taken together, the exclusion of all other major cell types implies 
that GR exerts its essential function during lung 
lineage, namely lipo- and/or myofibroblasts. 
It should be also noted that previous studies ablating GR in the central nervous 
system precluded that GR has a critical impact on lung function through regulatory 
action in the nervous system and in particular within the nervous control of 
respiratory movements and/or reflexes (Tronche et al., 1999).  
 
5.7. Conclusion and Outlook 
Progression through the later phases of murine lung development requires a 
developmental switch from the pseudoglandular phase characterized by proliferation 
and growth, towards growth arrest and differentiation, which are necessary for 
terminal maturation during the c
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g, the present work demonstrates that epithelial 
timing of this process co-incides with the increase of pulmonary GR expression as 
well as the surge in fetal corticosteroid levels observed from E16.5 until birth. In 
agreement with these pre-conditions, gene targeting experiments in this study proved 
that GR exerts key functions during lung morphogenesis by initiating the transition to 
the developmental phase of reduced proliferation and terminal differentiation.  
In contrast to common understandin
GR is dispensable for the completion of murine lung development. Instead, 
conditional gene inactivation evidenced that GR serves its essential role in the 
mesenchyme and more precisely in cells of the fibroblast lineage. Glucocorticoid 
signalling in these cells has a major impact on the composition of the extracellular 
matrix and thereby modulates mesenchymal-epithelial interactions. Moreover, it 
influences regulatory complexes of lung development such as TGFβ or FGF 
signalling which are known to participate in the proliferative and morphogenetic 
control. 
Identification of the critical cell type and the central effects in vivo should facilitate the 
investigation of the molecular mechanisms at their basis and this may finally allow 
the identification of interaction partners participating in the essential functions of GR 
during lung development. 
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6. Materials and Methods 
 
5.8. Materials 
 
6.1.1. Chemicals and enzymes 
In general, chemicals and enzymes were purchased from the following companies: 
 
Chemicals 
BioRad, Munich 
Difco, Detroit 
Fluca, Neu-Ulm 
VWR international, Darmstadt 
Roth, Karlsruhe 
Serva, Heidelberg 
Sigma-Aldrich, Munich 
Applichem, Darmstadt 
 
Radionucleotides 
Amersham, Braunschweig 
 
Enzymes 
Roche, Mannheim 
New England Biolabs, Schwalbach 
Invitrogen, Karlsruhe 
Stratagene, Heidelberg 
Promega, Heidelberg 
 
 
6.1.2. Standard solutions 
10x PBS (phosphate buffered saline) 
1.37M  NaCl 
100mM Na2HPO4 
27mM  KCl 
20mM  KH2PO4 
pH 7.2 
 
TE 
10mM  Tris/HCl, pH8.0 
1mM  EDTA 
 
50x TAE (Tris acetate EDTA buffer) 
2M   Tris base 
50mM  EDTA 
250mM  NaAc 
pH 7.8 (glacial acidic acid) 
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20x SSC (standard sodium citrate buffer) 
H 7.0 
3M   NaCl 
0.3M   NaCitrate 
p
 
10x TBE 
2
250mM NaAc 
M  Tris 
pH 7.8 (glacial acetic acid) 
a 
50mM  EDTA 
 
6.1.3. Medi
LB-medium 
10g  Bacto-Trypto (Difco) 
o) 
ved 
5g  yeast extract (Difc
l 5g  NaC
ad 1l   H2O 
pH 7.2 (NaOH), autocla
 
B-agarL  
1x  LB-medium 
ar (Difco) 1.5%  (w/v) bacto ag
 
6.1.4. Bacteria 
NM554 
This bacterial strain pr
cloning of plasmids. Tr
ovided by Stratagene was used as standard host for the 
ansformation of plasmids into preparations of competent 
d by heat-shock at 42°C. 
L250
bacteria was performe
 
E  
r ET-recombination according to Copeland/Court (Lee et 
.1. They contain the lambda prophage recombination 
ncoding the Flp recombinase. The transcription 
lp rec ase can be induced by arabinose while the recombination system 
mperature-sensitive repressor. Therefore, the bacteria are 
nly shifted to 42°C when recombination is desired.  
 and p
These bacteria were used fo
al., 2001), described in 6.3
system (Yu et al., 2000) and a gene e
of the F ombin
is under control of a te
t 32°  are ogrown a C and
 
6.1.5. Plasmids 
pConst Indu 
These plasmids, generated and provided by Dr. Erich Greiner (Evotec, Germany), 
d to  the targeting constructs for the insertion of a Cre or CreERT2 
logous recombination in bacteria. The plasmids 
on-improved Cre recombinase (Shimshek et al., 
r a fu  consisting of the latter and a mutated ligand-binding domain 
man n receptor (Feil et al., 1997). In addition, the plasmids harbor an 
tte flanked by two FRT sites, which can therefore be 
inase. 
were use  prepare
cassette into a BAC vector by homo
contain a cassette encoding the cod
2002 o sion protein) 
of the hu  estroge
ampicillin istance res  casse
removed by the Flp recomb
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6.1.6. Primers for genotyping 
Primers  purchased
 
 were  from MWG Biotech AG, Munich and the following conditions 
plied:
 and Rosa26: 
were ap
 
GR alleles
 
95°C 5min  
 95°C 30s 
63°C 
72°C 
45s 
60s 
35x 
72°C 5min 
 
 
4°C ∝
 
GR1 Forward 5´ – GGC ATG CAC ATT ACG GCC TTC T – 3´ 
AG CAG CCA GCT TAC AGG A – 3´ GR4 Reverse 5´ – GTG T
 TCT CAT TCC ATG TCA GCA TGT – 3´ GR8 Reverse 5´ – CCT
amplicons: GRwt ? 225bp, GRflox ? 275bp, GRnull ? 390bp 
 – TCT GCT GCC TCC TGG CTT CTG A – 3´ 
 
Rosa1 Forward 5´
Rosa2 Reverse 5´ – CCA GAT GAC TAC CTA TCC TCC CA – 3´ 
 Reverse 5´ – AAG CGC ATG CTC CAG ACT GCC T – 3´ Rosa3
amplicons: ROSA26 locus ? 270bp, ROSA26 Cre reporter ? 420bp 
ol1-Cre and Tie2-CreERT2: 
n  
30s 
 
C
 
95°C 5mi
95°C 
59°C 
72°C 
45s 
60s 
35x 
72°C 
4°C 
5min 
∝
 
 
 
CreERT2_f Forward 5´ – TCC AAC CTG CTG ACT GTG CAC CA – 3´ 
CreERT2_r Reverse 5´ – GTC AGT GCG TTC AAA GGC CAG G – 3´ 
amplicon: Cre ? 450bp 
 
Spc-Cre: 
 
95°C 5min  
95°C 30s 
35x 54°C 45
72°C 60s 
s 
72°C 
4°C 
5min 
∝ 
 
 
Spc-Cre1 Forward 5´ – GGC TAT ACG TAA CAG GG – 3´ 
Spc-Cre2 Reverse 5´ – TCG ATG CAA CGA GTG ATG AG – 3´ 
amplicon: Cre ? 500bp 
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5.9. Standard techniques in molecular biology 
 
6.2.1. Cloning into plasmid vectors and sequencing 
vectors was performed following standard 
protocols as described in Sambrock et al. (1989). Methods to obtain DNA fragments 
and vectors to clone the different plasmid constructs included PCR amplification, 
(sequential) digestion with restriction enzymes, dephosphorylation of DNA ends with 
Shrimp alkaline phosphatase (Roche), phosphorylation of DNA ends with 
po otidekinase as well as ligation of DNA fragments using T4-DNA-ligase. 
o n of DNA fragments from agarose gels was performed using the Qiaquick 
e ction n NM554 were 
ge  trans y agar plates. 
Re inant p rmants as 
MWG Biotech AG, Munich from plasmid DNA using 
0 n app ri
 
6.2 olo -Cre 
rmed using Pfu-polymerase and the following program: 
95°C, 30s/63°C, 1min/72°C, 1min, 35 cycles; finally 72°C, 10min 
 
5´homology arm for mSftp-Cre transgene
Cloning of DNA fragments into plasmid 
lynuc
latio
le
Is
G l-Extra Kit (Qiage ). Competent bacteria of the strain E.Coli 
nerally formed b  heat-shock at 42°C and spread on LB-
comb lasmid DNA was then isolated from positive transfo
described in section 6.2.3.1. 
equencing was performed at S
1 µM of a ropriate p mer. 
.2. Hom gy arms of the construct used to generate the mSftpc
transgene 
Preparative PCRs were perfo
 
  
as template served a mSftpc BAC DNA preparation 
 
5endf forward 5´ – GTT TAA ACA CAC CCA CGG TGA GA – 3´ Spc or 
Spc5endrev reverse 5´ – ATC CAT TTT GTA AGG TTT CTC TCT C – 3´ 
am
 
pc-Cre transgene
plicon: 397bp 
3´homology arm for mSft  
s template served a mSftpc BAC DNA preparation 
forward 5´ – AGC GTA TCT AGA GTG AGT GTG ATT GTG 
TGT GT – 3´ 
a
 
Spc3endfor 
Spc3endr reverse 5´ – AAC CAT GCT AGC GTT TAA ACA GTG TGC 
ACC TCT ATG – 3´ 
ev 
am : 365
 
plicon bp 
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6.2.3. Isolation of DNA 
 
Bacterial cultures were inoculatied and grown overnight in 2ml LB-medium containing 
 
suspended in 300µl buffer P1 and alkaline lysis was achieved by addition of 300µl 
 preparation was 
entrifuged at 14 000rpm for 10min, the supernatant was transferred into a new tube 
of 600µl isopropanol. The pellet, resulting 
ashed once in 70% ethanol to 
move salt, air dried and resuspended in 40µl TE buffer. The concentration and 
qual pre w  gel 
fter ate 
50m  co 25
overnight. Lysates were prepared as described for the mini-prep using 5ml of the 
resp s P1 r c
was filtered through cheese cloth  precipitated by addition of 10ml 
entrifugation at 8 000rpm for 15min. The pellet was resuspended in 
ml QBT buffer and applied to an equilibrated Q20 column. The DNA was washed 
twice with 2ml QC buffer before elution with 800µl warm QF buffer (70°C) The eluate 
was again precipitated with 560µl isopropanol (centrifugation at 14 000rpm for 
10min), the pellet washed with 70% ethanol, air dried and resuspended in 25µl TE 
buffer. As for the Mini-prep, the concentration and quality of the preparation were 
verified spectrophotometrically and by gel electrophoresis after appropriate restriction 
digestion of the BAC. 
 
6.2.3.1 Isolation of plasmid DNA from bacteria 
Bacterial cultures were inoculated and grown overnight in 2ml (mini-prep) or 50ml 
(midi-prep) of LB-medium containing the appropriate antibiotic (100µg/ml ampicillin or 
50µg/ml kanamycin). Isolation of plasmid DNA was done using the Quiagen Mini spin 
or Midi/Maxi Kit (Cartridges) according to instructions supplied by the manufacturer. 
 
6.2.3.2 Isolation of BAC DNA from bacteria 
 
Due to its size (about 150-200kb circular supercoiled DNA) and low abundance (1-2 
copies/bacterium), modified protocols were applied for the isolation of BAC DNA from 
bacteria. All reagents and columns were from Quiagen.  
 
6.2.3.3 Mini-prep of BAC DNA 
 
25µg/ml chloramphenicol. After centrifugation at 3 000rpm for 10min, the pellet was
re
buffer P2. Following neutralization by 300µl buffer P3, the
c
and the DNA was precipitated by addition 
from centrifugation at 14 000rpm for 10min was w
re
ity of the paration ere verified spectrophotometrically and by
elec
 
trophoresis a appropri restriction digestion of the BAC. 
6.2.3.4 Midi-prep of BAC DNA 
 
l LB-medium ntaining µg/ml chloramphenicol were inoculated and grown 
ective buffer -P3. Afte entrifugation at 4 000rpm for 10min, the supernatant 
 and the DNA was
isopropanol and c
1
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6.2.3.5 Isolation of DNA from mouse tails and organs 
NID-prep
 
 
fter weaning around four weeks after birth, mice were labelled with an earmark and 
 
e next morning, proteinase K was 
A
a piece of tail was taken (1-2mm). The latter was digested in 200µl NID buffer
containing 2µl proteinase K at 56°C overnight. Th
heat-inactivated by incubation at 96°C for 10min and the resulting DNA preparation 
was used as template for genotyping the mice by PCR (section 5.1.6.). 
 
NID buffer 
 
50mM  KCl 
2
.1mg/ml gelatin 
ail-prep
10mM  Tris/HCl (pH8.3) 
2mM  MgCl  
0
0.45%  NP40 
0.45%  Tween20 
 
T  
To obtain higher amounts of pure DNA for Southern or dot blot analysis, a larger 
en and digested in 760µl tail buffer with 40µl 
C overnight. The reactions were agitated on a shaking 
piece of tail (~5mm) was tak
proteinase K (10mg/ml) at 56°
incubator for 5min, 260µl of saturated NaCl were added and the mixture agitated 
again. The precipitate was spun down by centrifugation for 10min at 13 000rpm and 
800µl of the supernatant were transferred into a pre-spun 2ml Heavy Phase Lock Gel 
tube (Eppendorf). The same volume of Phenol/Chloroform/Isoamyl Alcohol (25:24:1) 
was added and mixed well by repeated inversion before centrifugation at 13 000rpm 
for 5min. The aqueous phase was transferred to a new tube, 600µl isopropanol were 
added and the DNA was allowed to precipitate for 5min with light agitation. 
Subsequent to centrifugation at 13 000rpm for 10min, the resulting pellet was 
washed with 70% ethanol, air dried and resuspended in 100µl TE buffer. 
 
Tail buffer 
 
50mM  Tris/HCl, pH8 
100mM EDTA 
100mM NaCl 
mediate transfer to ice. After addition of 10µl 5x OLB-C, 5µl [α-32P]-dCTP 
1%  SDS 
 
 
6.2.4. Southern blot analysis 
6.2.4.1 Synthesis of radioactively labeled DNA probes 
The generation of radioactive labelled DNA probes was performed using a modified 
protocol of Feinberg (Feinberg and Vogelstein, 1983). Around 100ng of the 
appropriate DNA fragment were filled up with water to achieve a final volume of 33µl. 
The DNA strands were separated by incubation at 95°C for 5min followed by 
im
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(3000Ci/mmol) and 2µl Klenow polymerase (2U/µl) the reaction was incubated for a 
ddition to the pre-heated hybridization buffer, the labeled probe was 
minimum of 2h at 37°C. 
Prior to a
denatured for 5min at 95°C followed by immediate transfer on ice. 
 
5x OLB-C (stored at –20°C) 
100µl Sol.A 
250µl Sol.B 
150µl Sol.C 
 
Sol.O  
625µl  2M Tris/HCl, pH 8  
25µl 1M MgCl2 
50µl 
1   
2   H2Odd 
 
Sol.A 
1ml  Sol.O
 
 
µl ea mM dATP, dGTP, dTTP  
 
.B
18 µl  β-mercaptoethanol 
5 ch 100
Sol   
2M HEPES, pH6.6 (adjust pH with 4M NaOH) 
 
Sol.C  
random Hexamers pd (N)6 
50 OD260units dissolved in 550µl TE 
 
6.2.4.2 Southern transfer of genomic DNA 
Appropriate DNA preparations were digested by restriction enzymes, separated on 
an agarose gel, transferred to a membrane and hybridized with a radioactive probe. 
The transfer of the separated DNA from the gel to the membrane was performed 
following the protocol of Southern (Southern, 1975). 
Approximately 30µg of a tail-prep were digested with the desired restriction enzyme/s 
oaded onto a 1% agarose gel (poured with 1x TAE) and separated for 5-
hrs with 90V using 1x TAE as running buffer. The DNA was first partially 
ated by 10min incubation of the gel in 0.25M HCl followed by denaturation of 
atment of the gel with 0.4M NaOH. 
 to a positively charged nylon membrane in 20x SSC with a 
lo rook and Russell, 2001) overnight. After equilibrating the 
embrane in 20x SSC, the blot was built in the following order: 1x Whatman, gel, 
embrane, 3x Whatman rinsed in 20x SSC, 3x Whatman (dry), stack of filter papers 
mounted with a small weight. The next morning, the membrane was rinsed briefly in 
H 8.0 and dried at room temperature (RT). The DNA 
was fixed on the membrane by UV-light (Stratalinker UV 1800, Stratagene) using the 
overnight, l
6
depurin
DNA through 3x15min tre
The DNA was transferred
capillary b t (Samb
m
m
25mM NaP-buffer, 1mM EDTA p
auto crosslinking program.  
 
1M NaP buffer 
71g Na2HPO4 (hydrogen-free) or 89g Na2HPO4 (H2O)2 were dissolved in 800ml 
H2Odd and adjusted with H3PO4 (85%) to pH 7.2. H2Odd was added to 1l total volume 
and the buffer was autoclaved. 
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6.2.4.3 Transfer of genomic DNA by dot blot 
Dot blot allows large-scale screening of genomic DNA for the presence of a specific 
sequence, e.g. a transgene. The DNA is fixed on a nylon membrane using a vacuum 
ot blot manifold system (Schleicher & Schüll).  d
3µl 2M NaOH were added to
blot is built a
 27µl of a tail-prep and the mix was incubated for 10min 
ccording to the manufacturer’s instructions including 
followed by the membrane, both rinsed in 2x SSC. The DNA was 
ucked into the membrane followed by addition of 200µl 10x SSC per 
briefly in 25mM NaP buffer, 1mM EDTA 
pH 8.0 and dried at RT. The DNA was fixed on the membrane by UV-light 
(Strata V 180  the auto crosslinking program. 
 
6.2.4.4 ization with radioactively labelled probes 
The hy  o  fixed on a nylon membrane (by Southern or 
dot blot), was performed following the protocol of Church and Gilbert (Church and 
Gilbert, 1984). The membrane was briefly rinsed in 25mM NaP buffer, 1mM EDTA 
pH 8.0 nsferred to a glass tube filled with pre-heated hybridization buffer 
(Churc ed to the Church-Gilbert buffer 
and hy  at 65°C. The next morning, the 
membrane was rinsed 2x10min in the glass tube in washing buffer, wrapped in Saran 
foil an odak) in a cassette containing an intensifier screen 
t -80°  
or determination of transgene copy number, the membrane was exposed to a 
elative band intensities were assessed 
sequent quantification by Aida V 2.0. 
at RT. The 
2x Whatman 
applied and s
well. The membrane was removed, rinsed 
linker U 0, Stratagene) using
 Hybrid
bridization f the genomic DNA,
 and tra
h-Gilbert buffer). The denatured probe was add
bridization was performed overnight
d exposed to either a film (K
a
F
C or a phosphoimager screen at RT. 
phosphoimager screen for several days and r
by phosphoimager (BAS-1800; Fuji) and sub
The band originating from the endogenous gene was calculated as two copies.  
If the membrane needed to be hybridized with a second probe, the old probe was 
removed by 20min incubation of the membrane in 0.4M NaOH at RT followed by 
subsequent rinsing in 0.25M NaP buffer, 1mM EDTA 3x for 10min.  
 
6.2.4.5 Hybridization buffer (Church-Gilbert) 
50ml   1M NaP buffer, pH 7.2 
35ml  20% SDS (Bio-RAD) 
200µl  0,5M EDTA, pH 8.0 
H2Odd ad 100ml  
 
Washing buffer 
40ml  1M NaP-buffer  
50ml  20% SDS (Bio-RAD) 
2ml  0,5M EDTA, pH 8.0 
H2Odd ad 1l  
pre-heated to 8
 
0°C before use, otherwise stored at RT 
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6.2.5. Genotype determination by PCR 
To determine the genotype of a mouse by PCR, 2µl genomic DNA prepared from a 
piece of tail (section 6.2.3.5.) were analyzed using Taq-DNA-polymerase (Roche) in 
a 25µl reaction volume according to the manufacturer’s instruction.  
The conditions for all genotyping PCRs performed in this study were as indicated in 
section 6.1.6. together with the oligo sequences.  
 
PCR products were mixed with 6x loading buffer and separated on a 2% agarose gel 
containing 2µl ethidiumbromide (10mg/ml) per 150ml gel. 
 
6x loading buffer 
0.25%  bromophenol blue 
0.25%  xylene cyanol FF 
acteria 
ecombinant DNA molecules were generated by homologous recombination in 
land and Court (Lee et al., 2001; Yu 
 
ous ector. In the present study, the acceptor vector 
bacte ome (BAC) harboring ~163kb of genomic DNA 
52D1 sen from the NCBI CloneFinder homepage 
(http://www.ncbi.nlm.nih.gov/genome/clone/clonefinder/CloneFinder.html
15%  Ficoll 400 
 
6.2.6. Pulse-field gel electrophoresis (PFGE) 
This technique applies an alternating voltage gradient and has been developed to 
electrophoretically separate large pieces of DNA beyond the resolution of standard 
agarose gel electrophoresis (>15-20kb) (Schwartz and Cantor, 1984). BAC DNA 
preparations were appropriately digested and resolved on a 1% Sea-plug low melting 
point agarose (Sigma) gel in 0.5x TAE running buffer using the following parameters: 
initial tswitch=0.5s, final tswitch=20s, included angle α=120°, │E│=6V/cm, I≈140mA, total 
time T=14h and cooling at 14°C. The gel was afterwards stained with ethidium 
bromide 1:20 000 in water. 
 
 
5.10. Generation of transgenic mice 
6.3.1. Modification of a BAC by homologous recombination in b
R
bacteria (ET-cloning) using the method of Cope
et al., 2000). This method allows the integration of a linear DNA sequence into a
homolog region of an acceptor v
was a rial artificial chromos
(RP24-2 8) that was cho
). The BAC 
as ordered at the Children’s Hospital Oakland Research Institute 
ori.org
w
(http://bacpac.ch ) and the ends of the genomic insert were sequenced and 
d to the  to verify the identity and integrity of the BAC clone. 
logous recombination in EL250 cells to insert a 
et  enc ed Cre recombinase (Cre) (Shimshek et al., 2002) 
and an ampicillin resistance cassette flanked by two FRT sites. For the Tie2-CreERT2 
nsisting of a codon-improved 
re recombinase (Cre) (Shimshek et al., 2002) and a mutated ligand-binding domain 
f the human estrogen receptor (ERT2) (Feil et al., 1997). 
 
blaste   mouse genome
This BAC was modified by homo
cass te oding a codon-improv
this cassette contained the CreERT2 fusion protein co
C
o
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6.3.2. Preparation of the Cre-containing plasmid and the linear fragment for 
e to contain about 50bp overlap to 
 a 365bp 3´homology arm 
 PCR. The 5´homology arm contained the ATG of the mSftpc gene 
arm started with the beginning of the first intron. With 
ers n sites were introduced into the homology arms 
ms into the plasmid pConst, subsequent analytical 
of  plasmid and finally the release of the linear targeting 
onstruct. The following restriction sites were introduced into the 5´homology arm: An 
e EcoRV restriction site in pConst) 
rst digested with XbaI and NheI to generate sticky ends 
nd cloned downstream of the FRT-flanked ampicillin cassette into the modified 
; NheI digested and dephosphorylated). The 
mology arms, one upstream of the Cre coding 
sequence and one downstream of the FRT-flanked ampicillin resistance cassette 
ent was 
 off 
ini-prep of the BAC, present in the former host bacteria, was prepared according to 
section 6.2.3.3. The competent EL250 cells were thawed on ice and the 
electroporation cuvettes were pre-cooled on ice as well. A series of 1µl, 2µl and 5µl 
homologous recombination 
To introduce a linear DNA fragment by homologous recombination into a genomic 
DNA sequence, the linear fragment has to be flanked by fragments homologous to 
the acceptor sequence, the homology arms. It has been shown (Zhang et al., 1998) 
hat the homology arms and the acceptor DNA havt
achieve high recombination efficiency.  
In order to introduce the Cre cassette into the BAC harboring the genomic sequence 
f the mouse Sftpc locus, a 397bp 5´homology arm ando
were amplified by
at its 3´end and the 3´homology 
iothe prim additional restrict
the arallowing the cloning of 
igestion the modifiedd
c
EcoRV halfsite at the 3´end (reconstitution of th
and a PmeI halfsite at the 5´end (generation of a PmeI restriction site in pConst). Into 
the 3´homology arm an XbaI restriction site was introduced at the 5´end. At its 3’end, 
a PmeI site was followed by a NheI halfsite (generation of a NheI restriction site in 
pConst).  
The PCR products were separated on an agarose gel and isolated as described 
before (section 6.2.5.). The 5´homology arm ending with the ATG was 
phosphorylated using polynucleotidekinase (Roche) and cloned in front of the Cre 
coding sequence into the pConst plasmid (EcoRV digested and dephosphorylated). 
he 3´homology arm was fiT
a
pIndu (containing the 5´homology arm
final targeting vector containing both ho
was released from the plasmid by PmeI digestion and the linear fragm
isolated by phenol/chloroform extraction.  
 
6.3.3. Preparation of competent bacteria for transformation with the BAC 
Single colonies of EL250 bacteria (Copeland/Court) were inoculated in 5ml LB-
medium at 32°C. 2ml of the overnight culture were transferred to 50ml LB-medium 
and incubated at 32°C for 3-4hrs. When reaching the log phase (OD=0.4-0.5), the 
cells were cooled on ice and centrifuged for 10min at 4°C, 3 000rpm. The cell pellet 
was resuspended in 50ml of ice cold 10% glycerol and centrifuged again for 10min at 
4°C, 3 000rpm. After a total of three washing steps, the supernatant was poured
and the pellet was resuspended in the remaining 10% glycerol resulting in a final 
volume of 0.6-0.7ml. 50µl aliquots of the cells were transferred into pre-cooled 
eppendorf tubes and frozen in liquid nitrogen.  
 
6.3.4. Re-transformation of the BAC 
M
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of the BAC mini-prep were added to 50µl competent cells respectively, followed 
electroporation at 2.3kV (BioRad Ge
200Ω). 1ml LB-medium was added afterwards, the cells were transferred into 
by 
ne Pulser, 25µF with Pulse controller set to 
e modified BAC. Since the cassette is flanked by two FRT sequences, it can be 
excised by the Flp-recombinase, which can be induced in EL250 bacteria by L-
µg/ml 
erformed with subsequent diagnostic 
igestion by analytical pulse-field gel electrophoresis (PFGE). 
Eppendorf tubes and incubated for 1h at 32°C. Finally 100µl of the cells were plated 
directly on LB-plates containing chloramphenicol (25µg/ml), whereas the remaining 
cells were centrifuged, resuspended in 100µl LB-medium and plated on a second 
chloramphenicol plate. 
 
6.3.5. Preparation of competent bacteria for homologous recombination 
Single colonies were picked from EL250 bacteria containing the desired BAC clone 
and inoculated in 5ml LB-medium/chloramphenicol (25µg/ml) at 32°C overnight 
(O/N). The next day, 2ml of the O/N culture were transferred into 50ml LB-medium 
and incubated at 32°C for 3-4hrs. When cells reached the log phase (OD=0.4-0.5), 
the RED-recombination system was induced by 15min shaking in a 42°C water bath. 
After incubation, the cells were rapidly cooled down and incubated on ice for 10-
40min. Subsequent washing steps with 10% glycerol, resuspension and freezing in 
50µl aliquots followed, as described in section 6.3.3. 
 
6.3.6. ET recombination and removal of the ampicillin resistance cassette 
0.1pmol of the linearized and purified construct were electroporated into the RED-
induced bacteria at 2.3kV (BioRad Gene Pulser, 25µF with Pulse controller set to 
200Ω). The cells were incubated in additional 1ml LB-medium for 1h as described 
before and plated on LB-plates containing chloramphenicol (25µg/ml) and ampicillin 
(50µg/ml) followed by incubation at 32°C (at least for 16hrs). Colonies were picked 
and BAC mini-preps were performed followed by diagnostic digestion with frequent 
cutting enzymes to verify successful ET-recombination. 
The Cre and CreERT2 constructs contain an ampicillin resistance cassette to select 
for the BAC that underwent homologous recombination with the construct. After 
homologous recombination in bacteria, the resistance cassette was removed from 
th
arabinose (Sigma). Of the recombined clone, a 5ml O/N culture (containing 25
chloramphenicol) was incubated at 32°C and the next day a 1:50 dilution of the 
culture was prepared and incubated at 32°C until cells reached an OD of 0.5. Then 
cells were treated for 1h with 0.1% L-arabinose at 32°C, diluted 1:10, incubated an 
additional hour and plated onto chloramphenicol (25µl/ml) LB-plates followed by 
incubation at 32°C. After O/N incubation, colonies were picked and transferred into 
5ml LB-medium (containing 25µg/ml chloramphenicol). After O/N incubation, a small 
aliquot of the culture was incubated for few hours in LB-medium containing 
chloramphenicol (25µl/ml) and ampicillin (50µg/ml) to verify the loss of the ampicillin 
resistance cassette by negative selection. From a culture that was not growing in 
ampicillin LB-medium, a BAC mini-prep was p
d
 
6.3.7. Preparation of linearized BAC DNA using a gel filtration column 
100µg of BAC Midi DNA from the verified clone were digested O/N with NotI which 
was then heat-inactivated at 65°C for 10min. ~50ml Sepharose CL4b were 
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equilibrated to injection buffer, degassed and used to pour a column in a 5ml plastic 
pipette. After application of the digested BAC, injection buffer was continuously 
added from a reservoir and 300µl fractions were collected. Fractions containing DNA 
were identified by UV-spectroscopy and analyzed by pulse-field gel electrophoresis. 
 
Injection buffer 
10mM  Tris/HCl, pH 7.5 
.1M  EDTA 
100mM NaCl 
 for the presence of a vaginal 
laque the following morning. Positive females were sacrificed the morning after the 
mating by cervical dislocation, the oviducts were removed and transferred into 37°C-
ytes 
0
 
6.3.8. DNA microinjection in mouse oocytes 
The microinjection of DNA into mouse oocytes was performed according to the 
protocol of Hogan (Hogan et al., 1994). Superovulated fertilized FVB/N females were 
used as source of oocytes. To induce superovulation, females were first injected 
intraperitoneally with PMS-gonadotropin (Sigma) and 48 hours later with chorion-
gonadotropin (Sigma). After administration of chorion-gonadotropin, the females 
were mated with FVB/N males and were analyzed
p
warm M2-medium. Oocytes were isolated and cumulus cells surrounding the ooc
were removed by hyaluronidase treatment (100mg/ml in M2-medium; Sigma). 
Oocytes were then rinsed in M2-medium, transferred into M16-medium and 
incubated at 37°C. For microinjection, 30 oocytes were transferred in an injection 
syringe containing M2-medium and placed under a microscope with two 
micromanipulator setups connected to a hydraulic control system (Eppendorf 
femtoJet). Oocytes were fixed with a blunt pipette and the tip of the injection needle 
was filled with the prepared DNA. The DNA was injected at a concentration of 1µg/µl 
or 2µg/µl in a volume of 1-2pl into the larger male pronucleus and oocytes were 
subsequently incubated for 2hrs in M16-medium at 37°C and controlled for their 
vitality.  
To transfer the oocytes into foster mothers, pseudopregnant FVB/N females (mated 
with vasectomized males one day before) were intraperitoneally injected with Ketavet 
and Rompun (0.01ml of a 1:10 in PBS diluted solution per g bodyweight) to 
anesthetize the animals. To transfer the oocytes, the operation site was desinfected 
with EtOH, the abdominal cavity was opened and the oviduct was pulled out. Using a 
binocular the oocytes were injected into the oviduct, it was returned to the abdominal 
cavity and the wound was closed with clamps. The females delivered 18 days after 
the surgery and 5-15% of the offspring were expected to be transgenic. 
 
M2-medium 
20ml  10x A 
3.2ml  10x B 
2ml  33mM sodiumpyruvate (Serva) 
2ml  171.4mM CaCl2 (H2O)2 
16.8ml 250mM HEPES (sodiumsalt, Sigma) 
156ml  H2O 
800mg BSA (Serva) 
pH 7.4 (NaOH) 
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M16-medium 
20ml  10x A 
20ml  10x B 
2ml  33mM sodiumpyruvate (Serva) 
1.4mM CaCl2 (H2O)2 
rva) 
10x A
2ml  17
156ml  H2O 
800mg BSA (Se
pH 7.4 (NaOH) 
 
       10x B 
0mM NaHCO3 
nimal treatment  
amoxifen
47mM  NaCl     25
47.75mM KCl     max. 5mg phenol red (Sigma) 
11.9mM KH2PO4    
232.8mM sodium lactate (Sigma)  
55.6mM D-glucose    
0.6g/l  penicillin (Seromed)  
0.5g/l  streptomycin (Seromed)  
 
 
5.11. Mouse work 
All mouse lines were maintained on a C57Bl6 background and respective wildtype 
mice for backcrosses were obtained by Charles River Laboratories (Wilmington, 
USA). In the case of the two germ line mutations, heterozygous animals were mated 
to generate litters containing mutants (GRnull/null, dedicated GRnull, or GRdim/dim, 
dedicated GRdim) as well as controls (GRwt/wt). Litters containing conditional mutant 
mice were generally produced by crossing GRflox/wt and Cre-positive animals with 
GRflox/flox animals. 
 
6.4.1. A
6.4.1.1 Treatment with tamoxifen 
Tamoxifen (Sigma) was dissolved in sunflower seed oil/ethanol (10:1) mixture at a 
final concentration of 10mg/ml. Eight weeks old mice were injected intraperitoneally 
with 1mg of tamoxifen twice per day for five consecutive days. Vehicle-treated 
animals were injected with 100µl of sunflower seed oil/ethanol mixture. 
 
T  
s and 4,5ml sunflower seed oil (Sigma) were added to 50mg tamoxifen 
Afte rotation for about 2hrs at room temperature to dissolve the 
n, th n was stored at 4°C and used for up to three days. 
500µl EtOHab
(Sigma). r slow 
tamoxife e solutio
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6.4.1.2 Treatment with bromodeoxyuridine (BrdU) 
re t ean section, mothers were injected intraperitoneally with 300mg 2hrs befo he cesar
BrdU/kg bodyweight.  
 
BrdU 
250mg BrdU (Sigma) were disso
 solution were in
lved in 16.7ml PBS (15mg/ml stock) by incubation at 
jected per g bodyweight. 50°C. 20µl stock
 
6.4.1.3 Treatment with Dexamethasone 
Animals were intraperitoneally injected with 0.1mg dexamethasone/kg bodyweight 
and sacrificed 2hrs later. 
 
Dexamethasone and vehicle 
1mg Dexamethasone (γ-irradiated, Sigma) was solved in 1ml EtOHabs. This stock 
u ng in a final concentration of 0.01µg/µl. The 
nimals were injected with 10µl/g bodyweight. 
 embryos to survive was to be tested, they were quickly dissected 
ut at RT and allowed to recover on a warming plate. A piece of the tail was taken 
ungs were dissected. After a quick wash 
d to 4% PFA and further processed as described below. 
 
ion profiling 
ared with the 
Neasy Mini Kit (Qiagen, Hilden, Germany) and its quality was assessed on RNA 
gilent, Santa Clara, CA, USA). Microarray experiments were carried out 
wo time points, E16.5 and E18.5, were analyzed for mutants and controls, 
respectively. For each of the four conditions, five GeneChips were used each 
representing one animal. 
Analysis of array data was performed using the R/Bioconductor and MeV 4.0. Data 
was normalized and expression values were computed using the gcrma method. 
Ontology analyses were performed using GOstat and ErmineJ. Analysis of 
transcription factor binding sites in co-expressed genes was performed using 
oPossum (Ho Sui et al., 2005)  using the following parameters: top 20% of mouse-to-
solution was diluted 1:100 in H2Odd res lti
a
 
 
5.12. Collection of organs 
Staged matings were set up to harvest embryonic organs at desired stages of fetal 
development. The presence of a vaginal plug in the morning indicated successful 
mating and noon of the same day was designated E0.5. At the embryonic day of 
interest, mothers were killed by CO2 and the pups were collected by caesarean 
section. Complete uteri were removed and transferred to ice-cold PBS. Only when 
the potential of the
o
from dead pups for later genotyping and the l
in PBS they were transferre
5.13. RNA analyses – gene express
Profiling of gene expression was performed on lungs from GRCol1-Cre animals and 
controls that were collected as described in section 6.5. Left lung lobes were 
immersed in RNALater solution (Sigma-Aldrich Chemie GmbH, Munich, Germany), 
snap frozen in liquid nitrogen and stored at -80°C. Total RNA was prep
R
LabChips (A
using GeneChip Mouse Genome 430A 2.0 arrays (Affymetrix, Santa Clara, CA, 
USA). Labeling of the target RNAs (1-2µg total RNA), hybridization and scanning of 
the microarrays was performed according to manufacturer’s instruction.  
T
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human conserved non-coding regions (minimum 65% identity) within 2 000bp of the 
Matrix match score was set to 
rotein analyses – extraction of mouse organs and preparation for 
transcription site (in both directions) were considered. 
80%, results with z-score>10 and Fischer exact test p<0.001 were considered as 
significant. 
 
5.14. P
immunohistochemical analysis 
reparation of paraffin sectionsP  
Lungs were collected as described in section 6.5. and fixed in 4% PFA overnight. 
r 5min in PBS at RT and dehydrated 
3x 30min 70%EtOH, 1h 80%EtOH, 1h 
ed by O/N incubation in xylene. The next day, the xylene 
as replaced with fresh xylene and organs were heated up to 56°C for 1h. The 
6°C. Half of the xylene was replaced with liquid paraffin 
 embedded in paraffin in small plastic 
olds and cooled down to solidify the paraffin. These paraffin blocks were stored at 
°C.  
embedded organs, with a thickness of 6µm for 
Organs were subsequently washed 3x fo
through an increasing ethanol gradient: 
95%EtOH, 3x 1h EtOHabs. The dehydrated organs were incubated in glass cuvettes 
for 30min in xylene follow
w
following steps took place at 5
and the organs were incubated in this 1:1 xylene/paraffin mixture for 1h.  
Subsequently, the samples were immersed in pure paraffin which was exchanged 
three times every hour. Finally the organs were
m
4
Paraffin sections of the 
immunohistochemistry or 4.5µm for histology, were prepared using a microtome 
(Leica). The sections were smoothened on a 42°C water bath, transferred onto 
Superfrost Plus glass slides (Roth) and fixed O/N at 56°C. The paraffin sections were 
stored at RT. 
 
4% PFA 
300ml H2Odd were heated to 100°C in a microwave and subsequently mixed with 
150ml room temperature H2Odd. 20g PFA were helped to dissolve therein by addition 
of 100µl 10M NaOH on a stirring plate. When the PFA was dissolved completely, 
50ml of 10x PBS were added and the solution cooled down to 4°C. 
For all applications with β-galactosidase staining, 5mM EGTA and 2mM MgCl2 were 
added.  
 
PBS 
120mM NaCl 
28mM  Na2HPO4 
2.5mM KH2HPO4 
 
 
5.15. Histology and immunohistochemistry 
6.8.1. Immunohistochemistry using paraffin sections 
Paraffin sections were deparaffinized 3x for 10min in xylene and rehydrated through 
a decreasing ethanol gradient: 2x5min EtOHabs, 2x5min 95%EtOH and 2x5min 
70%EtOH followed by H2Odd. The endogenous peroxidase activity was blocked by  
3%H2O2 diluted in PBS/MetOH (1:1) at RT for 10min. After washing in PBS, antigen 
retrieval was performed by microwave treatment (100s 900W, 7min 270W) in 1x 
Antigen Retrieval Citra buffer (Biogentex). The cooled sections were rinsed 4x in 
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H2Odd and 1x in PBS, circled with Pap-Pen (Beckman Coulter) and incubated for 
30min with blocking solution (5% normal swine serum (NSS; Dako) in PBST) in a 
humid chamber. Incubation with the first antibody was performed at 4°C O/N. 
Sections were rinsed next day 3x for 5min in PBS and afterwards incubated for 
0min with the appropriate biotinylated secondary antibody (Vector). After 3x5min 
m was 
 the manufacturer (streptavidin-biotin-
oxidase; Vector Laboratories). The sections 
benzidine (DAB; Sigma) dissolved in Tris/HCl or 
3
washing in PBS, 30min incubation with the VECTASTAIN ABC syste
performed according to the instruction of
complex coupled with horse radish per
were stained with 3,3-diamino
Histogreen (Vector) and the staining was controlled using a binocular. After the 
reaction was stopped by replacing DAB with PBS, Hematoxylin QS (Vector) was 
applied to lightly counterstain. Finally, the sections were dehydrated in an increasing 
ethanol gradient (H2Odd, 70%EtOH, 95%EtOH and EtOHabs 2x3min each) followed by 
2x5min incubation in xylene and mounted with Eukitt (O.Kindler). 
Following primary antibodies were used in the indicated dilution in 5%NSS/PBST: 
polyclonal rabbit anti-GR (M-20 - Santa Cruz) 1:200; polyclonal rabbit anti-Cre 
(Kellendonk et al., 1999) 1:2000; monoclonal mouse anti-BrdU (Bu20a - Dako) 1:100; 
monoclonal hamster anti-T1α (8.1.1 - Developmental Studies Hybridoma Bank) 
1:500; polyclonal rabbit anti-collagen I/III (#2150-2555 - Biotrend) 1:20; mouse anti-
alpha smooth muscle actin (mouse ascites fluid, clone 1A4, #2547 - Sigma). 
 
PBST 
PBS with 0.1% Triton-X-100 (Sigma) 
 
DAB 
10mg DAB (diaminobenzidine tablet; Sigma) were dissolved in 15ml Tris/HCl pH7.5, 
ltered through paper filter and 12µl H2O2 were added immediately prior to use. fi
 
Histogreen POD substrate kit 
1ml  buffer (solution #2) 
2drops solution #1 
vortex 
2drops solution #3 
vortex 
 
6.8.2. Hematoxylin/eosin staining of paraffin sections 
 were deparaffinized for 3x10min in xylene and rehydrated 
hanol gradient (2x5min EtOHabs, 2x5min 95%EtOH, 2x5min 
0%EtOH and 3min tap water). 3min incubation in Gill’s hematoxylin No.3 (Sigma) 
in in 0.5%HCl in 70%EtOH. The signal 
unning tap water before the sections 
were transferred to eosin staining solution for 2min. After a quick wash in H2Odd and 
70%EtOH, 30s 95%EtOH, 
4.5µm paraffin sections
hrough a decreasing ett
7
was followed by a quick wash in H2Odd and 1m
was allowed to differentiate for 5min under r
dehydration through an increasing ethanol gradient (30s 
1min EtOHabs) the sections were incubated 2x5min in xylene and finally mounted with 
Eukitt (O. Kindler). 
 
Eosin staining solution 
30ml  1% Eosin (Sigma) 
270ml  70%EtOH 
3ml  glacial acetic acid 
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6.8.3. β-galactosidase staining 
For whole mount β-galactosidase stainings, organs of interest were dissected and 
fixed in 4% PFA (5mM EGTA, 2mM MgCl2) for 30-45min. After 10min in PBS (5mM 
EGTA, 2mM MgCl2) and washing buffer, respectively, the specimen were incubated 
at 37°C overnight in X-gal staining solution. The next day, organs were washed in 
washing buffer and kept in PBS at 4°C for analysis. In some cases, stained organs 
were postfixed overnight with 4% PFA at 4°C and further processed for paraffin 
sections as described in section 6.7. 
For β-galactosidase staining on cryosections, dissected organs were frozen in O.C.T. 
compound (Tissue Tek, Sakura Finetek) on ethanol/dry ice and 10µm sections were 
prepared using a cryostat (Leica). The slides were immersed for 15min in 4% PFA 
and β-galactosidase staining was performed as described for whole mount samples. 
Sections were counterstained with Eosin (Sigma), dehydrated and mounted with 
Eukitt (O.Kindler). 
 
Washing buffer 
5mM   EGTA 
mM   MgCl2 2 
 sodium-deoxycholat 0.01% 
0.02%  NP-40 
issolved in PBS d
 
X-gal staining solution 
5mM   EGTA, pH8.0 
mM   MgCl  2 2
lat 
4 6
Dimethylformamide; Applichem) 
 dehydrated in an 
0.01%  sodium-deoxycho
0.02%  NP-40 
10mM  K3[Fe(CN)6] 
 K [Fe(CN) ] 10mM 
0.5mg/ml X-gal (50mg/ml in 
ed in PBS dissolv
 
6.8.4. Electron microscopy and semi-thin sections 
Specimen were fixed in Karnovsky’s solution for 24h at RT,
increasing ethanol gradient and embedded in Araldit. Sections were prepared on a 
Leica Ultracut UCT with a thickness of 500nm for semi-thin section and 70nm for 
electron microscopy. For the latter, sections were contrasted with uranyl acetate and 
lead citrate before inspection with the Zeiss EM900. Semi-thin sections were stained 
with toluidine blue and used for morphometric measurements. Series of pictures 
were acquired and evaluated using the processing and analysis software imageJ 
(available at http://rsb.info.nih.gov/ij/index.html).  
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Table 4: Genes differentially regulated at E16.5 in GRCol1-Cre lungs compared to 
control littermates 
Table 5: Overview of the analysis of Tie2-CreERT2 transgenic offspring 
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Table 4
li
: Genes differentially regulated at E16.5 in GRCol1-Cre lungs compared to control 
ttermates 
   Dev Mut Dev Ctr E16.5 E18.5 Dev Diff 
Probe -ID Symbol Description M p-val M p-val M p-val M p-val M p-val
1424903_at Jarid1d jumonji, AT rich interactive domain 
1D (Rbp2 like) 
3,14 0,018 -4,32 0,003 -4,32 0,002 3,14 0,024 7,46 0,001
1449038_at Hsd11b1 hydroxysteroid 11-beta 
dehydrogenase 1 
3,73 0,000 4,44 0,000 -3,48 0,000 -4,19 0,000 -0,71 0,300
1437932_a_at Cldn1 claudin 1 0,29 0,160 0,45 0,049 -2,06 0,000 -2,22 0,000 -0,16 0,599
1448700_at G0s2 G0/G1 switch gene 2 0,99 0,000 0,83 0,000 -1,96 0,000 -1,80 0,000 0,16 0,490
1460303_at Nr3c1 nuclear receptor subfamily 3, 
group C, member 1 
0,75 0,001 0,73 0,001 -1,72 0,000 -1,70 0,000 0,02 0,937
1449851_at Per1 period homolog 1 (Drosophila) 0,90 0,005 1,98 0,000 -1,56 0,000 -2,64 0,000 -1,08 0,017
1418936_at Maff v-maf musculoaponeurotic 
fibrosarcoma oncogene family, 
protein F (avian) 
1,20 0,003 2,41 0,000 -1,42 0,001 -2,63 0,000 -1,21 0,029
1425428_at Hif3a hypoxia inducible factor 3, alpha 
subunit 
-0,02 0,926 0,25 0,356 -1,38 0,000 -1,65 0,000 -0,27 0,461
1420760_s_at Ndrl N-myc downstream regulated-like 1,99 0,000 1,86 0,001 -1,34 0,004 -1,21 0,012 0,13 0,830
1422677_at Dgat2 diacylglycerol O-acyltransferase 2 0,08 0,670 0,61 0,009 -1,27 0,000 -1,80 0,000 -0,52 0,082
1422904_at Fmo2 flavin containing monooxygenase 
2 
1,63 0,000 5,02 0,000 -1,23 0,003 -4,62 0,000 -3,39 0,000
1417143_at Edg2 endothelial differentiation, 
lysophosphatidic acid G-protein-
coupled receptor, 2 
-0,63 0,000 0,70 0,000 -0,81 0,000 -2,14 0,000 -1,33 0,000
1424633_at Camk1g calcium/calmodulin-dependent 
protein kinase I gamma 
-0,37 0,043 -1,23 0,000 -0,72 0,001 0,14 0,465 0,85 0,003
1425631_at Ppp1r3c protein phosphatase 1, regulatory 
(inhibitor) subunit 3C 
0,56 0,000 -0,19 0,152 -0,69 0,000 0,07 0,609 0,75 0,000
1428455_at Col14a1 procollagen, type XIV, alpha 1 -0,03 0,816 0,81 0,000 -0,68 0,000 -1,53 0,000 -0,85 0,001
1416714_at Irf8 interferon regulatory factor 8 1,16 0,000 2,15 0,000 -0,68 0,001 -1,67 0,000 -0,98 0,001
1448228_at Lox lysyl oxidase -0,02 0,862 0,04 0,753 -0,68 0,000 -0,73 0,000 -0,06 0,728
1420854_at Eln elastin 1,21 0,000 3,01 0,000 -0,67 0,001 -2,47 0,000 -1,80 0,000
1418596_at Fgfr4 fibroblast growth factor receptor 4 0,80 0,000 1,26 0,000 -0,66 0,000 -1,12 0,000 -0,46 0,034
1451407_at Jam4 junction adhesion molecule 4 1,46 0,000 1,05 0,000 -0,61 0,000 -0,20 0,115 0,41 0,026
1418086_at Ppp1r14a protein phosphatase 1, regulatory 
(inhibitor) subunit 14A 
0,51 0,000 0,61 0,000 -0,60 0,000 -0,71 0,000 -0,11 0,283
1421275_s_at Socs4 suppressor of cytokine signaling 4 -0,16 0,214 -0,81 0,000 -0,59 0,000 0,06 0,655 0,65 0,002
1432543_a_at Klf13 Kruppel-like factor 13 0,53 0,002 1,16 0,000 -0,59 0,001 -1,22 0,000 -0,63 0,010
1424131_at Col6a3 procollagen, type VI, alpha 3 1,10 0,000 1,26 0,000 -0,59 0,005 -0,75 0,001 -0,16 0,543
1452025_a_at Zfp2 zinc finger protein 2 -0,95 0,000 -0,76 0,000 0,62 0,000 0,44 0,006 -0,19 0,347
1449310_at Ptger2 prostaglandin E receptor 2 
(subtype EP2) 
1,40 0,000 2,21 0,000 0,63 0,002 -0,17 0,362 -0,81 0,006
1416958_at Nr1d2 nuclear receptor subfamily 1, 
group D, member 2 
0,77 0,000 0,79 0,000 0,64 0,000 0,62 0,000 -0,01 0,927
1420377_at St8sia2 ST8 alpha-N-acetyl-neuraminide 
alpha-2,8-sialyltransferase 2 
0,27 0,178 -1,63 0,000 0,64 0,004 2,54 0,000 1,90 0,000
1427527_a_at Pthlh parathyroid hormone-like peptide -1,51 0,000 -1,02 0,000 0,67 0,002 0,18 0,365 -0,49 0,081
1422893_at Sfmbt1 Scm-like with four mbt domains 1 -0,77 0,001 -0,79 0,002 0,68 0,004 0,70 0,004 0,02 0,947
1450191_a_at Sox13 SRY-box containing gene 13 0,27 0,151 0,69 0,002 0,70 0,001 0,28 0,164 -0,42 0,123
1417552_at Fap fibroblast activation protein 0,05 0,823 0,15 0,520 0,73 0,003 0,63 0,013 -0,10 0,751
1425528_at Prrx1 paired related homeobox 1 0,34 0,009 -0,20 0,118 0,74 0,000 1,29 0,000 0,55 0,005
1454953_at Rnf157 ring finger protein 157 -1,16 0,000 -0,47 0,030 0,76 0,001 0,08 0,708 -0,69 0,023
1449005_at Slc16a3 solute carrier family 16 
(monocarboxylic acid 
transporters), member 3 
-0,58 0,018 -0,16 0,508 0,81 0,002 0,39 0,118 -0,43 0,205
1422924_at Tnfsf9 tumor necrosis factor (ligand) 
superfamily, member 9 
-0,88 0,000 -0,40 0,021 0,86 0,000 0,38 0,028 -0,48 0,038
1418937_at Dio2 deiodinase, iodothyronine, type II -0,94 0,000 -0,07 0,723 0,98 0,000 0,11 0,580 -0,88 0,004
1418989_at Ctse cathepsin E 0,98 0,000 -0,87 0,002 1,10 0,000 2,95 0,000 1,85 0,000
1418139_at Dcx doublecortin -0,49 0,084 -0,36 0,224 1,28 0,000 1,14 0,001 -0,13 0,735
1455893_at Rspo2 R-spondin 2 homolog (Xenopus 
laevis) 
0,46 0,058 -1,83 0,000 1,33 0,000 3,62 0,000 2,29 0,000
1418580_at Rtp4 receptor transporter protein 4 3,81 0,000 5,89 0,000 1,72 0,003 -0,35 0,517 -2,08 0,012
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 Ov  sis of Tie2-CreER ge pr
Founder Sex Copy Number
 
 
Table 5: erview of the analy T2 trans nic offs ing 
Transgenic 
Offspring 
LacZ 
analysis R
Expected 
ecombination Pattern
T1 ♀ ?  13 ?  - 
T2 ♀ ?  15 ?  - 
T3 ♂ 13 ?  ?  ?  
T4 ♀ 5?   -  
T5 ♀ n.d. -  - 
T6 ♂ .d- n . -  
T7 ♂ ?  6 ?  ?  
T8 ♀ ?  5   
T9 ♀ ?  14 ?  ?  
T10 ♂ - n.d. -  
T11 ♂ - n.d. -  
T12 ♀ 17 -  ?  
T13 ♂ - n.d. -  
T14 ♂ ?  1 ?  - 
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